1 | A (migalastat) | 1件: Migalastat Migalastat | 1件: D10359
D10359
| - | - | 1件: 19 19 |
2 | A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine | 3件: Clarithromycin Clarithromycin, Clofazimine, Rifabutin | 3件: D00276
D00276
,
D00278
,
D00424
| - | - | 1件: 96 96 |
3 | A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) | - | - | - | - | 1件: 60 60 |
4 | A multistrain probiotic product (DSF) | - | - | - | - | 1件: 97 97 |
5 | A Natural Remedy for Rheumatoid Arthritis vs. Common Drugs | - | - | - | - | 1件: 46 46 |
6 | A novel synthetic, orally-administered, non-peptide small molecule, which acts as | - | - | - | - | 1件: 254 254 |
7 | A novel synthetic, orally-administered, non-peptide small molecule, which acts as an agonist of the melanocortin-1 receptor (MC1R) | - | - | - | - | 1件: 51 51 |
8 | A single booster dose of the Moderna mRNA COVID-19 vaccine | - | - | - | - | 1件: 28 28 |
9 | A-1293543.74 | - | - | - | - | 1件: 96 96 |
10 | A-623 | - | - | - | - | 1件: 49 49 |
11 | A-623 or AMG 623 | - | - | - | - | 1件: 66 66 |
12 | A-dopamine | 1件: Dopamine Dopamine | 2件: D00633
D00633
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
13 | A-F-A-F (NovoRapid-FIASP-NovoRapid-FIASP) | - | - | - | - | 1件: 299 299 |
14 | A-glucosidasi acida umana ricombinante coniugata con multiple copie di bis-mannosio-6- fosfato-tetra-mannosio glicano sintetico (NEOGAA) | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: D11744
D11744
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
15 | A01AC02 | - | - | - | - | 1件: 28 28 |
16 | A042917017 | - | - | - | - | 1件: 21 21 |
17 | A04AD10 | - | - | - | - | 1件: 298 298 |
18 | A07DA03 | - | - | - | - | 1件: 97 97 |
19 | A07EA06 | - | - | - | - | 1件: 66 66 |
20 | A10BK03 | - | - | - | - | 1件: 65 65 |
21 | A11HA02 | - | - | - | - | 1件: 93 93 |
22 | A16AB04 | - | - | - | - | 1件: 19 19 |
23 | A16AX06 | - | - | - | - | 1件: 19 19 |
24 | A16AX07 | - | - | - | - | 1件: 240 240 |
25 | A4250 | - | - | - | - | 4件: 93 93, 296, 297, 338 |
26 | A4250 (1200 µg) | - | - | - | - | 1件: 338 338 |
27 | A4250 (200 µg) | - | - | - | - | 1件: 338 338 |
28 | A4250 (400 µg) | - | - | - | - | 1件: 338 338 |
29 | A4250 (600 µg) | - | - | - | - | 1件: 338 338 |
30 | A4250 (odevixibat) | 1件: Odevixibat Odevixibat | 1件: D11716
D11716
| 1件: SLC10A2 SLC10A2 💬 | 1件: Bile secretion Bile secretion 💬 | 1件: 338 338 |
31 | A4250-015 | - | - | - | - | 1件: 297 297 |
32 | A4I Antagonist | - | - | - | - | 1件: 13 13 |
33 | A: 1 dosis | - | - | - | - | 1件: 97 97 |
34 | A: PTH (1-84) | - | - | - | - | 1件: 235 235 |
35 | AAC Hexal | - | - | - | - | 1件: 299 299 |
36 | Aadipose-Derived Mesenchymal Stem Cells | - | - | - | - | 1件: 6 6 |
37 | AAV BBP-631 | - | - | - | - | 1件: 81 81 |
38 | AAV directed hLDLR gene therapy | - | - | - | - | 1件: 79 79 |
39 | AAV-RPGR | - | - | - | - | 1件: 90 90 |
40 | AAV1-gamma-sarcoglycan vector injection | - | - | - | - | 1件: 113 113 |
41 | AAV2-GDNF | - | - | - | - | 1件: 6 6 |
42 | AAV2-GDNF gene therapy | - | - | - | - | 1件: 17 17 |
43 | AAV2-REP1 | - | - | - | - | 1件: 90 90 |
44 | AAV2/5-hPDE6B | - | - | - | - | 1件: 90 90 |
45 | AAV2/5-hRKp.RPGR | - | - | - | - | 1件: 90 90 |
46 | AAV2/8.TBG.hARSB | - | - | - | - | 1件: 19 19 |
47 | AAV2/8LSPhGAA | - | - | - | - | 1件: 256 256 |
48 | AAV2CUhCLN2 (3x10^12 particle units) | - | - | - | - | 1件: 19 19 |
49 | AAV5-HRKP.RPGR | - | - | - | - | 1件: 90 90 |
50 | AAV8-RPGR | - | - | - | - | 1件: 90 90 |
51 | AAV8.TBG.hLDLR | - | - | - | - | 1件: 79 79 |
52 | AAV9 BBP-812 | - | - | - | - | 1件: 307 307 |
53 | AAV9-CAG-coh-SGSH | - | - | - | - | 1件: 19 19 |
54 | AAV9-GLB1 | - | - | - | - | 1件: 19 19 |
55 | AAVrh.10-hMPSIIIA | - | - | - | - | 1件: 19 19 |
56 | AAVrh.10cuARSA | - | - | - | - | 1件: 19 19 |
57 | AAVrh.10CUCLN2 | - | - | - | - | 1件: 19 19 |
58 | AAVrh.10CUhCLN2 vector 2.85x10^11 genome copies | - | - | - | - | 1件: 19 19 |
59 | AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies | - | - | - | - | 1件: 19 19 |
60 | AB (antibiotics) | - | - | - | - | 1件: 97 97 |
61 | AB 1003 | - | - | - | - | 1件: 2 2 |
62 | AB1010 | - | - | - | - | 6件: 2 2, 5, 6, 13, 46, 96 |
63 | ABA, open-label (OL) | - | - | - | - | 1件: 46 46 |
64 | Abacavir | 1件: Abacavir Abacavir | 2件: D00891
D00891
,
D07057
| - | - | 4件: 2 2, 135, 265, 325 |
65 | Abacavir (ABC) | 1件: Abacavir Abacavir | 2件: D00891
D00891
,
D07057
| - | - | 1件: 325 325 |
66 | Abacavir (ABC)+Lamivudine (3TC)+Zidovudine (AZT) | 3件: Abacavir Abacavir, Lamivudine, Zidovudine | 4件: D00353
D00353
,
D00413
,
D00891
,
D07057
| - | - | 1件: 325 325 |
67 | Abacavir 300mg twice daily | 1件: Abacavir Abacavir | 2件: D00891
D00891
,
D07057
| - | - | 1件: 265 265 |
68 | Abacavir sulfate | 2件: Abacavir Abacavir, Sulfate ion | 2件: D00891
D00891
,
D07057
| - | - | 1件: 265 265 |
69 | Abacavir sulfate, Lamivudine and Zidovudine | 4件: Abacavir Abacavir, Lamivudine, Sulfate ion, Zidovudine | 4件: D00353
D00353
,
D00413
,
D00891
,
D07057
| - | - | 1件: 265 265 |
70 | Abalimumab | - | - | - | - | 1件: 97 97 |
71 | Abalimumab bio-originatore | - | - | - | - | 1件: 107 107 |
72 | Abatacept | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 26件: 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 |
73 | Abatacept (ABA) | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 97 97 |
74 | Abatacept (ABA) + Methotrexate (MTX), double-blind (DB) | 2件: Abatacept Abatacept, Methotrexate | 3件: D00142
D00142
,
D02115
,
D03203
| 4件: CD80 CD80, CD86, DHFR, DHFR2 💬 | 17件: Allograft rejection Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 46 46 |
75 | Abatacept (BMS-188667) | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 46 46 |
76 | Abatacept (CTLA4-Ig) | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 44 44 |
77 | Abatacept (IV) | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 46 46 |
78 | Abatacept (SC) | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 46 46 |
79 | Abatacept + csDMARD | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 46 46 |
80 | Abatacept + Methotrexate | 2件: Abatacept Abatacept, Methotrexate | 3件: D00142
D00142
,
D02115
,
D03203
| 4件: CD80 CD80, CD86, DHFR, DHFR2 💬 | 17件: Allograft rejection Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 46 46 |
81 | Abatacept + Vaccines | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 46 46 |
82 | Abatacept Active Treatment | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 50 50 |
83 | Abatacept also known as Orencia also known as CTLA4-Ig | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 49 49 |
84 | Abatacept combination product (ACP) | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 46 46 |
85 | Abatacept Delayed-Onset Treatment | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 50 50 |
86 | Abatacept Injection | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 3件: 11 11, 46, 107 |
87 | Abatacept Placebo | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 2件: 46 46, 53 |
88 | Abatacept Prefilled Syringe | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 46 46 |
89 | Abatacept SC | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 53 53 |
90 | Abatacept subcutaneous | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 50 50 |
91 | Abatacept, rituximab or tocilizumab | 3件: Abatacept Abatacept, Rituximab, Tocilizumab | 3件: D02596
D02596
,
D02994
,
D03203
| 4件: CD80 CD80, CD86, IL6R, MS4A1 💬 | 24件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
92 | ABBV-006 | - | - | - | - | 1件: 97 97 |
93 | ABBV-066 | - | - | - | - | 2件: 96 96, 97 |
94 | ABBV-0805 | - | - | - | - | 1件: 6 6 |
95 | ABBV-105 | - | - | - | - | 2件: 46 46, 49 |
96 | ABBV-105, A-1519938.0 | - | - | - | - | 1件: 46 46 |
97 | ABBV-119 | - | - | - | - | 1件: 299 299 |
98 | ABBV-154 | - | - | - | - | 2件: 46 46, 96 |
99 | ABBV-2222 | - | - | - | - | 1件: 299 299 |
100 | ABBV-257 | - | - | - | - | 1件: 46 46 |
101 | ABBV-3067 | - | - | - | - | 1件: 299 299 |
102 | ABBV-323 | - | - | - | - | 2件: 53 53, 97 |
103 | ABBV-323 Dose A | - | - | - | - | 1件: 97 97 |
104 | ABBV-323 Dose B | - | - | - | - | 1件: 97 97 |
105 | ABBV-3373 | - | - | - | - | 1件: 46 46 |
106 | ABBV-8E12 | - | - | - | - | 2件: 5 5, 7 |
107 | ABBV-951 | - | - | - | - | 1件: 6 6 |
108 | ABBV-CLS-7262 | - | - | - | - | 1件: 2 2 |
109 | ABC | - | - | - | - | 2件: 265 265, 325 |
110 | ABC008 | - | - | - | - | 1件: 15 15 |
111 | Abcertin | - | - | - | - | 1件: 19 19 |
112 | Abdominal compression | - | - | - | - | 2件: 6 6, 17 |
113 | Abdominal ultrasound | - | - | - | - | 1件: 231 231 |
114 | ABELCET | 1件: Amphotericin B Amphotericin B | 1件: D00203
D00203
| - | - | 1件: 299 299 |
115 | Abelmoschus manihot | - | - | - | - | 1件: 66 66 |
116 | Abemaciclib | 1件: Abemaciclib Abemaciclib | 1件: D10688
D10688
| 2件: CDK4 CDK4, CDK6 💬 | 29件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Breast cancer, Cell cycle, Cellular senescence, Chronic myeloid leukemia, Cushing syndrome, Endocrine resistance, Epstein-Barr virus infection, Glioma, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Measles, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Small cell lung cancer, T cell receptor signaling pathway, Tight junction, Viral carcinogenesis, p53 signaling pathway 💬 | 1件: 34 34 |
117 | Abetimus | 1件: Abetimus Abetimus | - | - | - | 1件: 49 49 |
118 | ABETIMUS SODIUM | 1件: Abetimus Abetimus | - | - | - | 1件: 49 49 |
119 | Abetimus sodium (LJP 394) | 1件: Abetimus Abetimus | - | - | - | 1件: 49 49 |
120 | AbGn-168H | - | - | - | - | 1件: 97 97 |
121 | ABH001 | 1件: ABH001 ABH001 | - | - | - | 1件: 36 36 |
122 | ABI-009, nab-rapamycin, albumin-bound rapamycin | 1件: Sirolimus Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 86 86 |
123 | ABI-M201 | - | - | - | - | 1件: 97 97 |
124 | Abiraterone | 1件: Abiraterone Abiraterone | - | - | - | 2件: 75 75, 81 |
125 | Abiraterone Acetate | 2件: Abiraterone Abiraterone, Acetate | - | - | - | 2件: 75 75, 81 |
126 | Abiraterone acetato | 1件: Abiraterone Abiraterone | - | - | - | 1件: 75 75 |
127 | Abituzumab | 1件: Abituzumab Abituzumab | - | - | - | 1件: 51 51 |
128 | Abituzumab 1500 mg | 1件: Abituzumab Abituzumab | - | - | - | 1件: 51 51 |
129 | Abituzumab 500 mg | 1件: Abituzumab Abituzumab | - | - | - | 1件: 51 51 |
130 | ABO-101 | - | - | - | - | 1件: 19 19 |
131 | ABO-102 | - | - | - | - | 1件: 19 19 |
132 | Abobotulinumtoxin A | - | - | - | - | 1件: 13 13 |
133 | ABP 501 | - | - | - | - | 1件: 46 46 |
134 | ABP 710 | - | - | - | - | 1件: 46 46 |
135 | ABP 710 - Biosimilar to infliximab | 1件: Infliximab Infliximab | 1件: D02598
D02598
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
136 | ABP 798 | - | - | - | - | 1件: 46 46 |
137 | ABP 798 - Biosimilar to rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
138 | ABP 798 Biosimilar to Rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
139 | ABP 959 | - | - | - | - | 1件: 62 62 |
140 | ABP 959 - biosimilar to eculizumab | 1件: Eculizumab Eculizumab | 1件: D03940
D03940
| 1件: C5 C5 💬 | 10件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 |
141 | ABP 959 - proposed biosimilar to eculizumab | 1件: Eculizumab Eculizumab | 1件: D03940
D03940
| 1件: C5 C5 💬 | 10件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 |
142 | ABPC | 1件: Ampicillin Ampicillin | 3件: D00204
D00204
,
D01251
,
D02119
| - | - | 1件: 84 84 |
143 | ABR-215062 | - | - | - | - | 1件: 13 13 |
144 | ABR-215062 sodium salt | - | - | - | - | 2件: 13 13, 96 |
145 | ABR-215757 | - | - | - | - | 2件: 49 49, 51 |
146 | Abrilumab | 1件: Abrilumab Abrilumab | 1件: D10540
D10540
| 2件: ITGA4 ITGA4, ITGB7 💬 | 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 |
147 | ABT 494 | - | - | - | - | 1件: 46 46 |
148 | ABT 494 12mg | - | - | - | - | 2件: 46 46, 96 |
149 | ABT 494 3mg | - | - | - | - | 2件: 46 46, 96 |
150 | ABT Humira | - | - | - | - | 1件: 96 96 |
151 | ABT-122 | - | - | - | - | 1件: 46 46 |
152 | ABT-199 | - | - | - | - | 1件: 49 49 |
153 | ABT-494 | - | - | - | - | 7件: 41 41, 46, 49, 96, 97, 107, 271 |
154 | ABT-494 15mg | - | - | - | - | 1件: 46 46 |
155 | ABT-494 30mg | - | - | - | - | 1件: 46 46 |
156 | ABT-555 | - | - | - | - | 1件: 13 13 |
157 | ABT-874 | - | - | - | - | 1件: 96 96 |
158 | ABT-874/Human monoclonal antibody against IL-12 | - | - | - | - | 1件: 13 13 |
159 | ABT-Humira | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 97 |
160 | ABT-SLV187 | - | - | - | - | 1件: 6 6 |
161 | ABX-1431 | 1件: ABX-1431 ABX-1431 | - | - | - | 1件: 13 13 |
162 | ABX-1431 HCl | 1件: ABX-1431 ABX-1431 | - | - | - | 1件: 13 13 |
163 | ABX464 | - | - | - | - | 3件: 46 46, 96, 97 |
164 | ABX464 100mg | - | - | - | - | 2件: 46 46, 97 |
165 | ABX464 25mg | - | - | - | - | 1件: 97 97 |
166 | ABX464 50mg | - | - | - | - | 2件: 46 46, 97 |
167 | ABY-035 | - | - | - | - | 1件: 271 271 |
168 | AC-203 | - | - | - | - | 1件: 36 36 |
169 | AC-203 1% Topical Ointment | - | - | - | - | 1件: 162 162 |
170 | AC0058TA | - | - | - | - | 1件: 49 49 |
171 | AC430 | - | - | - | - | 1件: 46 46 |
172 | Acalabrutinib | 1件: Acalabrutinib Acalabrutinib | 1件: D10893
D10893
| 1件: BTK BTK 💬 | 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 2件: 46 46, 61 |
173 | Acamprosate | 1件: Acamprosate Acamprosate | 2件: D02780
D02780
,
D07058
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 6 6, 206 |
174 | Acarbose | 1件: Acarbose Acarbose | 1件: D00216
D00216
| 5件: AMY2A AMY2A, AMY2B, GAA, GANC, MGAM 💬 | 7件: Carbohydrate digestion and absorption Carbohydrate digestion and absorption, Galactose metabolism, Lysosome, Metabolic pathways, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬 | 1件: 298 298 |
175 | Acazicolcept | - | - | - | - | 1件: 49 49 |
176 | ACC | - | - | - | - | 1件: 299 299 |
177 | ACC600Tabs | - | - | - | - | 1件: 299 299 |
178 | Accelerated 1 hour-infusion | - | - | - | - | 2件: 96 96, 97 |
179 | Accelerated 30 minutes-infusion | - | - | - | - | 2件: 96 96, 97 |
180 | Accelerometer | - | - | - | - | 1件: 17 17 |
181 | Access program - sildenafil citrate, Viagra, Revatio | 1件: Sildenafil Sildenafil | 2件: D02229
D02229
,
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
182 | Accordion Pill Carbidopa/Levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
183 | Accordion Pill ¿ Carbidopa/Levodopa 50/400 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
184 | Accordion Pill ¿ Carbidopa/Levodopa 50/500 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
185 | Accordion Pill? Carbidopa/Levodopa 50/400 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
186 | Accordion Pill? Carbidopa/Levodopa 50/500 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
187 | Accordion Pill¿ Carbidopa/levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
188 | Accordion Pill™ Carbidopa/Levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
189 | Accordion Pill™ Carbidopa/Levodopa 50/400 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
190 | Accordion Pill™ Carbidopa/Levodopa 50/500 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
191 | Accupro | - | - | - | - | 1件: 19 19 |
192 | Accuretic | 1件: Quinapril Quinapril | 2件: D00459
D00459
,
D03752
| 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 19 19 |
193 | ACE I, ATA II and Statins | - | - | - | - | 1件: 218 218 |
194 | ACE inhibitor | - | - | - | - | 1件: 66 66 |
195 | ACE inhibitor + statin | - | - | - | - | 1件: 66 66 |
196 | ACE Inhibitor or Angiotensin receptor antagonist | 1件: Angiotensin II Angiotensin II | 2件: D00150
D00150
,
D02014
| 2件: AGTR1 AGTR1, AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 66 66 |
197 | ACE-011 | - | - | - | - | 1件: 86 86 |
198 | ACE-031 (Extension of cohort 1 from core study, A031-03) | - | - | - | - | 1件: 113 113 |
199 | ACE-031 (Extension of cohort 2 from core study, A031-03) | - | - | - | - | 1件: 113 113 |
200 | ACE-031 (Extension of cohort 3 from core study, A031-03) | - | - | - | - | 1件: 113 113 |
201 | ACE-031 0.5 mg/kg q4wk | - | - | - | - | 1件: 113 113 |
202 | ACE-031 1.0 mg/kg q2wk | - | - | - | - | 1件: 113 113 |
203 | ACE-083 | - | - | - | - | 2件: 10 10, 113 |
204 | ACE-1334 | - | - | - | - | 1件: 51 51 |
205 | ACE-inhibitor | - | - | - | - | 1件: 218 218 |
206 | ACE/ARB | - | - | - | - | 1件: 66 66 |
207 | Acebilustat | 1件: Acebilustat Acebilustat | - | - | - | 1件: 299 299 |
208 | Aceclofenac | 1件: Aceclofenac Aceclofenac | 1件: D01545
D01545
| 3件: PTGES PTGES, PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
209 | ACEi | - | - | - | - | 2件: 66 66, 224 |
210 | ACEI/ARB and corticosteroids | - | - | - | - | 1件: 66 66 |
211 | Acellbia | - | - | - | - | 1件: 46 46 |
212 | ACENEURAMIC ACID | 1件: Aceneuramic acid Aceneuramic acid | 1件: D11016
D11016
| - | - | 1件: 30 30 |
213 | Aceneuramic Acid Extended-Release | 1件: Aceneuramic acid Aceneuramic acid | 1件: D11016
D11016
| - | - | 1件: 30 30 |
214 | Aceneuramic acid extended-release (Ace-ER) | 1件: Aceneuramic acid Aceneuramic acid | 1件: D11016
D11016
| - | - | 1件: 30 30 |
215 | Aceneuramic Acid Extended-Release Tablets | 1件: Aceneuramic acid Aceneuramic acid | 1件: D11016
D11016
| - | - | 1件: 30 30 |
216 | Acetamide | 1件: Acetamide Acetamide | - | - | - | 2件: 86 86, 154 |
217 | Acetaminophen | 1件: Acetaminophen Acetaminophen | 1件: D00217
D00217
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 16件: 11 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 |
218 | Acetaminophen Tab 650mg | 1件: Acetaminophen Acetaminophen | 1件: D00217
D00217
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 |
219 | Acetaminophen tablets | 1件: Acetaminophen Acetaminophen | 1件: D00217
D00217
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
220 | Acetaminophen/paracetamol | 1件: Acetaminophen Acetaminophen | 1件: D00217
D00217
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 35 35, 49 |
221 | Acetate | 1件: Acetate Acetate | - | - | - | 43件: 1 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 |
222 | ACETATO DI AMMONIO | - | - | - | - | 1件: 97 97 |
223 | Acetazolamide | 1件: Acetazolamide Acetazolamide | 2件: D00218
D00218
,
D01196
| 13件: CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 | 7件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 6件: 13 13, 90, 115, 155, 225, 230 |
224 | Acetazolamide Sandoz 250 | 1件: Acetazolamide Acetazolamide | 2件: D00218
D00218
,
D01196
| 13件: CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 | 7件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 1件: 225 225 |
225 | Acetic acid | 1件: Acetic acid Acetic acid | 1件: D00010
D00010
| - | - | 1件: 97 97 |
226 | Acetohydroxamic Acid | 1件: Acetohydroxamic acid Acetohydroxamic acid | 1件: D00220
D00220
| - | - | 1件: 251 251 |
227 | Acetohydroxamic Acid Oral Tablet [Lithostat] | 1件: Acetohydroxamic acid Acetohydroxamic acid | 1件: D00220
D00220
| - | - | 1件: 251 251 |
228 | Acetominofene | - | - | - | - | 2件: 11 11, 63 |
229 | Acetominophen | - | - | - | - | 1件: 63 63 |
230 | ACETYL- L- CARNITINE | 1件: Levocarnitine Levocarnitine | 3件: D02030
D02030
,
D02176
,
D04713
| - | - | 1件: 265 265 |
231 | Acetyl-L-carnitine | 2件: Acetylcarnitine Acetylcarnitine, Levocarnitine | 3件: D02030
D02030
,
D02176
,
D04713
| - | - | 1件: 298 298 |
232 | Acetyl-L-carnitine 1000mg 2X per day for 3 months | 2件: Acetylcarnitine Acetylcarnitine, Levocarnitine | 3件: D02030
D02030
,
D02176
,
D04713
| - | - | 1件: 298 298 |
233 | Acetylcarnitine | 1件: Acetylcarnitine Acetylcarnitine | - | - | - | 2件: 2 2, 265 |
234 | Acetylcholine | 1件: Acetylcholine Acetylcholine | - | - | - | 1件: 11 11 |
235 | Acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 20件: 6 6, 13, 19, 20, 34, 49, 51, 53, 58, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 |
236 | Acetylcysteine Effervescent Tablets | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 1件: 85 85 |
237 | ACETYLCYSTEINE SODIUM | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 1件: 299 299 |
238 | ACETYLSALICYLIC ACID | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: D00109
D00109
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 4件: 13 13, 46, 51, 210 |
239 | Acetylsalicylic acid at 1st visit, | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: D00109
D00109
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 |
240 | ACH-0144471 | - | - | - | - | 2件: 62 62, 222 |
241 | ACH-0144471 compresse | - | - | - | - | 1件: 222 222 |
242 | ACH-0145228 | - | - | - | - | 1件: 62 62 |
243 | ACH0144471 | - | - | - | - | 1件: 222 222 |
244 | ACH0144471 compresse | - | - | - | - | 1件: 222 222 |
245 | ACHIM as solute (10^9 intestinal microbes/ml) | - | - | - | - | 1件: 51 51 |
246 | Aciclin | - | - | - | - | 1件: 28 28 |
247 | Aciclovir | 1件: Acyclovir Acyclovir | 1件: D00222
D00222
| - | - | 3件: 13 13, 28, 60 |
248 | Acid mycophenolic (Myfortic) | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 222 222 |
249 | Acide folique | 1件: Folic acid Folic acid | 1件: D00070
D00070
| - | - | 1件: 46 46 |
250 | ACIDE TRANEXAMIQUE MYLAN 0,5 g/ 5 mL, solution injectable | - | - | - | - | 1件: 299 299 |
251 | ACIDO ASCORBICO | - | - | - | - | 1件: 10 10 |
252 | ACIDO ASCORBICO DC.IT | - | - | - | - | 1件: 10 10 |
253 | ACIDO DEOSSICOLICO | - | - | - | - | 1件: 94 94 |
254 | Acido Micofenolico | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 49 49 |
255 | Acido Obeticolico | - | - | - | - | 2件: 93 93, 94 |
256 | Acido Sialico - Sialic acid (INN: aceneuramic acid) | 1件: Aceneuramic acid Aceneuramic acid | 1件: D11016
D11016
| - | - | 1件: 30 30 |
257 | ACIDO TAUROURSODESOSSICOLICO | - | - | - | - | 1件: 2 2 |
258 | Acido ursodessicolico | - | - | - | - | 1件: 93 93 |
259 | Acidophilus | 1件: Lactobacillus acidophilus Lactobacillus acidophilus | 1件: D04349
D04349
| - | - | 1件: 97 97 |
260 | Acidum ascorbicum | 1件: Ascorbic acid Ascorbic acid | 1件: D00018
D00018
| - | - | 1件: 206 206 |
261 | ACIDUM ASCORBICUM D6 | 1件: Ascorbic acid Ascorbic acid | 1件: D00018
D00018
| - | - | 1件: 206 206 |
262 | Acipimox | 1件: Acipimox Acipimox | 1件: D07190
D07190
| - | - | 2件: 78 78, 265 |
263 | Acitretin | 1件: Acitretin Acitretin | 1件: D02754
D02754
| 5件: RARA RARA, RARB, RXRA, RXRB, RXRG 💬 | 19件: Acute myeloid leukemia Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬 | 1件: 37 37 |
264 | Aclasta | - | - | - | - | 3件: 13 13, 271, 274 |
265 | Aclasta 5 mg Infusionslösung | 1件: Zoledronic acid Zoledronic acid | 4件: D01968
D01968
,
D06378
,
D06379
,
D08689
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 |
266 | Aclasta 5mg solution for infusion | - | - | - | - | 1件: 13 13 |
267 | ACM | - | - | - | - | 1件: 49 49 |
268 | ACN00177 | - | - | - | - | 1件: 337 337 |
269 | Acomplia | 1件: Rimonabant Rimonabant | 1件: D05731
D05731
| 1件: CNR1 CNR1 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 193 193 |
270 | ACOMPLIA 20 mg film-coated tablets | 1件: Rimonabant Rimonabant | 1件: D05731
D05731
| 1件: CNR1 CNR1 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 193 193 |
271 | Acoramidis | - | - | - | - | 1件: 28 28 |
272 | Acotiamide | 1件: Acotiamide Acotiamide | - | - | - | 1件: 51 51 |
273 | Acoziborole | - | - | - | - | 1件: 65 65 |
274 | Acoziborole (SCYX-7158) | 1件: SCYX-7158 SCYX-7158 | - | - | - | 1件: 65 65 |
275 | ACP-001 | - | - | - | - | 1件: 78 78 |
276 | ACP-001 (TransCon hGH) | - | - | - | - | 1件: 78 78 |
277 | ACP-011 | - | - | - | - | 1件: 78 78 |
278 | ACP-103 | - | - | - | - | 1件: 6 6 |
279 | ACR16 | - | - | - | - | 1件: 8 8 |
280 | ACR16 10 mg | - | - | - | - | 1件: 8 8 |
281 | ACR16 22.5 mg | - | - | - | - | 1件: 8 8 |
282 | ACR16 45 mg | - | - | - | - | 1件: 8 8 |
283 | ACR16 hydrochloride, ASP2314 hydrochloride, FR310826 | - | - | - | - | 1件: 8 8 |
284 | ACR325 | 1件: ACR325 ACR325 | - | - | - | 1件: 6 6 |
285 | ACT | - | - | - | - | 1件: 13 13 |
286 | ACT - 064992 | - | - | - | - | 1件: 86 86 |
287 | ACT-050089 | - | - | - | - | 1件: 86 86 |
288 | ACT-050089 (Ro 61-0612) | - | - | - | - | 1件: 86 86 |
289 | ACT-064992 | - | - | - | - | 5件: 51 51, 85, 86, 88, 210 |
290 | ACT-064992 (macitentan) | 1件: Macitentan Macitentan | 1件: D10135
D10135
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 |
291 | ACT-064992 / JNJ-67896062 | - | - | - | - | 1件: 86 86 |
292 | ACT-064992/ JNJ-67896062 | - | - | - | - | 1件: 86 86 |
293 | ACT-064992D | - | - | - | - | 1件: 86 86 |
294 | ACT-1 | - | - | - | - | 1件: 13 13 |
295 | ACT-128800 | - | - | - | - | 1件: 13 13 |
296 | ACT-128800 Dose 1 | - | - | - | - | 1件: 13 13 |
297 | ACT-128800 Dose 2 | - | - | - | - | 1件: 13 13 |
298 | ACT-128800 Dose 3 | - | - | - | - | 1件: 13 13 |
299 | ACT-178418 | - | - | - | - | 1件: 86 86 |
300 | ACT-293987 | - | - | - | - | 3件: 51 51, 86, 88 |
301 | ACT-293987 (NS-304) | - | - | - | - | 1件: 86 86 |
302 | ACT-293987 / JNJ-67896049 | - | - | - | - | 1件: 84 84 |
303 | ACT-334441 | - | - | - | - | 1件: 49 49 |
304 | ACT-385781A | - | - | - | - | 1件: 86 86 |
305 | ACT-385781A (Actelion Epoprostenol) | 1件: Epoprostenol Epoprostenol | 2件: D00106
D00106
,
D01337
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
306 | ACT-434964 | - | - | - | - | 1件: 19 19 |
307 | Act-HiB | 1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | 4件: 14 14, 61, 62, 222 |
308 | ACT-HIB Polvere e solvente per soluzione iniettabile in siringa preriempita 0,5 ml | 1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | 2件: 61 61, 62 |
309 | Actemra | 1件: Tocilizumab Tocilizumab | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 46 46, 107 |
310 | Actemra(EU-licensed) | 1件: Tocilizumab Tocilizumab | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
311 | Actemra, MRA | 1件: Tocilizumab Tocilizumab | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 107 107 |
312 | Acteoside | 1件: Acteoside Acteoside | - | - | - | 1件: 66 66 |
313 | ACTH | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 5件: 13 13, 66, 145, 193, 222 |
314 | ACTH (Acthar) Gel | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 66 66 |
315 | Acthar | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 9件: 2 2, 13, 14, 46, 49, 50, 66, 84, 222 |
316 | Acthar 80 unit injection | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 66 66 |
317 | Acthar Gel | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 6件: 13 13, 46, 49, 50, 84, 222 |
318 | ACTHAR Gel (ACTH) | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 13 13 |
319 | ACTHAR Gel (adrenocorticotropic hormone) | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 84 84 |
320 | ACTHAR Gel 40 units twice weekly | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 84 84 |
321 | ACTHAR Gel 80 units twice weekly. | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 84 84 |
322 | Acthar high dose (80 U) | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 49 49 |
323 | Acthar Injectable Product | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 46 46 |
324 | Acthar low dose (40 U) | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 49 49 |
325 | ActHIB | 1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | 2件: 62 62, 66 |
326 | ACTHIB - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONCINO POLVERE+1 SIRINGA PRERIEMPITA SOLVENTE 0.5 ML | 1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | 2件: 62 62, 66 |
327 | Acthrel | 1件: Corticorelin ovine triflutate Corticorelin ovine triflutate | 1件: D03592
D03592
| 2件: CRHR1 CRHR1, CRHR2 💬 | 4件: Cushing syndrome Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
328 | ACTIMMUNE | 1件: Interferon gamma-1b Interferon gamma-1b | 1件: D00747
D00747
| 2件: IFNGR1 IFNGR1, IFNGR2 💬 | 18件: Chagas disease Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | 1件: 326 326 |
329 | Actimmune Registry | 1件: Interferon gamma-1b Interferon gamma-1b | 1件: D00747
D00747
| 2件: IFNGR1 IFNGR1, IFNGR2 💬 | 18件: Chagas disease Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | 1件: 326 326 |
330 | ActiMyo recording | - | - | - | - | 1件: 6 6 |
331 | Activated smart device | - | - | - | - | 1件: 299 299 |
332 | Active BMN 111: Daily subcutaneous injection of 15 ug/kg of BMN 111 | - | - | - | - | 1件: 276 276 |
333 | Active comparator | - | - | - | - | 2件: 6 6, 46 |
334 | Active Comparator receiving Extavia® | 1件: Interferon beta-1b Interferon beta-1b | 1件: D00746
D00746
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
335 | Active Control | - | - | - | - | 1件: 13 13 |
336 | Active drug (BIIB014) at 10, 30, 100, or 300 mg once daily. | - | - | - | - | 1件: 6 6 |
337 | Active drug: pimavanserin 17mg (2 strength tablets) | 1件: Pimavanserin Pimavanserin | - | - | - | 1件: 6 6 |
338 | Active Investigational Treatment ENT-01 | - | - | - | - | 1件: 6 6 |
339 | Active Stimulation | - | - | - | - | 1件: 46 46 |
340 | Active tDCS | - | - | - | - | 1件: 6 6 |
341 | Active topical NS2 1% dermatologic cream | - | - | - | - | 1件: 160 160 |
342 | Active tPCS | - | - | - | - | 1件: 6 6 |
343 | Active Treatment Group 7% Hypertonic Saline | - | - | - | - | 1件: 299 299 |
344 | Activity Monitor | 1件: Methamidophos Methamidophos | - | - | - | 1件: 113 113 |
345 | Actonel 5mg Film Coated Tablets | 1件: Risedronic acid Risedronic acid | 3件: D00942
D00942
,
D03234
,
D08484
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 |
346 | Actonel Once a Week 35 mg film-coated tablets | 1件: Risedronic acid Risedronic acid | 3件: D00942
D00942
,
D03234
,
D08484
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 |
347 | Actonel Once a week 5mg film coated tablets | 1件: Risedronic acid Risedronic acid | 3件: D00942
D00942
,
D03234
,
D08484
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 113 113 |
348 | Actonel/Optinate 5mg film-coated tablets | 1件: Risedronic acid Risedronic acid | 3件: D00942
D00942
,
D03234
,
D08484
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 |
349 | ACTOS (Pioglitazone) | 1件: Pioglitazone Pioglitazone | 2件: D00945
D00945
,
D08378
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 13 13 |
350 | Actos 15 mg | 1件: Pioglitazone Pioglitazone | 2件: D00945
D00945
,
D08378
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 2 2 |
351 | Actos 30 mg | 1件: Pioglitazone Pioglitazone | 2件: D00945
D00945
,
D08378
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 2 2 |
352 | Actos 45 mg | 1件: Pioglitazone Pioglitazone | 2件: D00945
D00945
,
D08378
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 2 2 |
353 | Actrapid 100 IU/ml, Solution for injection in a vial | - | - | - | - | 1件: 299 299 |
354 | Actrapid Penfill 100UI/ml | - | - | - | - | 1件: 299 299 |
355 | ActRIIA-IgG1Fc | - | - | - | - | 1件: 86 86 |
356 | ACU-4429 | - | - | - | - | 1件: 301 301 |
357 | Acupuncture | - | - | - | - | 2件: 46 46, 70 |
358 | Acute Antioxidant | - | - | - | - | 1件: 299 299 |
359 | Acycloguanosine | 1件: Acyclovir Acyclovir | 1件: D00222
D00222
| - | - | 2件: 46 46, 53 |
360 | Acyclovir | 1件: Acyclovir Acyclovir | 1件: D00222
D00222
| - | - | 2件: 13 13, 28 |
361 | Acylated and unacylated ghrelin dosages | 1件: Lenomorelin Lenomorelin | - | - | - | 3件: 193 193, 201, 202 |
362 | ACZ885 | - | - | - | - | 7件: 46 46, 84, 106, 107, 108, 266, 267 |
363 | ACZ885 (investigational) | - | - | - | - | 1件: 46 46 |
364 | ACZ885 150 mg (Canakinumab) | 1件: Canakinumab Canakinumab | 1件: D09315
D09315
| 1件: IL1B IL1B 💬 | 44件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | 1件: 107 107 |
365 | ACZ885 Drug Substance | - | - | - | - | 3件: 46 46, 106, 107 |
366 | ACZ885, 150mg/1.0ml | - | - | - | - | 2件: 266 266, 267 |
367 | ACZ885D | - | - | - | - | 1件: 108 108 |
368 | ACZ885G | - | - | - | - | 1件: 107 107 |
369 | AD 452 | - | - | - | - | 1件: 46 46 |
370 | AD 452 18 mg tablet | - | - | - | - | 1件: 46 46 |
371 | AD 452 4.5 mg Tablet | - | - | - | - | 1件: 46 46 |
372 | AD 452 9 mg tablet | - | - | - | - | 1件: 46 46 |
373 | AD-810N (zonisamide) | 1件: Zonisamide Zonisamide | 1件: D00538
D00538
| 8件: CACNA1G CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus 💬 | 1件: 6 6 |
374 | AD-MSC transdifferentiated HSCs (AD-HSCs) | - | - | - | - | 1件: 60 60 |
375 | Ad26.COV2-S.02 | - | - | - | - | 1件: 299 299 |
376 | Ad26.COV2.S | - | - | - | - | 5件: 13 13, 35, 46, 49, 51 |
377 | ADA gene transfer | - | - | - | - | 1件: 65 65 |
378 | ADA PBSC | - | - | - | - | 1件: 65 65 |
379 | ADA Umbilical Cord Blood Cells | - | - | - | - | 1件: 65 65 |
380 | Adagen | 1件: Pegademase Pegademase | 1件: D05384
D05384
| - | - | 1件: 65 65 |
381 | Adalimuab, Etanercept, Tocilizumab, or Abatacept | 3件: Abatacept Abatacept, Etanercept, Tocilizumab | 3件: D00742
D00742
,
D02596
,
D03203
| 5件: CD80 CD80, CD86, IL6R, LTA, TNF 💬 | 79件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
382 | Adalimumab | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 18件: 19 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 151, 160, 164, 222, 226, 269, 270, 271 |
383 | Adalimumab (20mg) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 107 107 |
384 | Adalimumab (40 mg) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
385 | Adalimumab (40mg) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 107 107 |
386 | Adalimumab (ADA) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
387 | Adalimumab (D2E7) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 271 |
388 | Adalimumab (Humira) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 222, 271 |
389 | Adalimumab (HUMIRA®) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
390 | Adalimumab (up to 9 months exposure) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
391 | Adalimumab - GP2017 | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
392 | Adalimumab - US licensed Humira | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
393 | Adalimumab 40 mg | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
394 | Adalimumab 40 mg eow or ew | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
395 | Adalimumab 40 mg sc every other week | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 271 271 |
396 | Adalimumab 40 mg subcutaneous (SC) every other week (EOW) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
397 | Adalimumab 40mg | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 |
398 | Adalimumab 40mg q2w | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
399 | Adalimumab 80 mg | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
400 | Adalimumab and Infliximab | 2件: Adalimumab Adalimumab, Infliximab | 2件: D02597
D02597
,
D02598
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
401 | Adalimumab and its biosimilars | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 271 271 |
402 | Adalimumab biosimilare | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 107 107 |
403 | Adalimumab delivered in current autoinjector | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
404 | Adalimumab delivered in current syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
405 | Adalimumab delivered in Physiolis autoinjector | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
406 | Adalimumab delivered in Physiolis syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
407 | ADALIMUMAB HUMIRA | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
408 | Adalimumab Injection | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 40 40, 46, 96 |
409 | Adalimumab Injection [Humira] | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 19 19 |
410 | Adalimumab PFS and Pen | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
411 | Adalimumab PRN | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
412 | Adalimumab with methotrexate | 2件: Adalimumab Adalimumab, Methotrexate | 3件: D00142
D00142
,
D02115
,
D02597
| 3件: DHFR DHFR, DHFR2, TNF 💬 | 71件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
413 | Adalimumab, current formulation | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
414 | Adalimumab, Etanercept, Golimumab or infliximab | 4件: Adalimumab Adalimumab, Etanercept, Golimumab, Infliximab | 4件: D00742
D00742
,
D02597
,
D02598
,
D04358
| 2件: LTA LTA, TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 271 271 |
415 | Adalimumab, new formulation | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
416 | Adalimumab, plus prednisone | 2件: Adalimumab Adalimumab, Prednisone | 2件: D00473
D00473
,
D02597
| 2件: NR3C1 NR3C1, TNF 💬 | 68件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
417 | Adalimumab, Solution for Injection 40 mg/ (0.8 ml) Pre-filled Syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
418 | ADALIMUMAB-EU | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
419 | Adalimumab-Pfizer | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
420 | Adalimummab | - | - | - | - | 1件: 46 46 |
421 | Adaptor: Hakko Adaptor | - | - | - | - | 1件: 6 6 |
422 | Adcirca | 1件: Tadalafil Tadalafil | 1件: D02008
D02008
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
423 | ADCIRCA 20 mg film-coated tablets | 1件: Tadalafil Tadalafil | 1件: D02008
D02008
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
424 | Adcirca® | 1件: Tadalafil Tadalafil | 1件: D02008
D02008
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
425 | Adderall XR | - | - | - | - | 1件: 13 13 |
426 | Adderall XR 10 mg | - | - | - | - | 1件: 13 13 |
427 | Adderall XR 5mg | - | - | - | - | 1件: 13 13 |
428 | Adefovir | 1件: Adefovir Adefovir | 1件: D02768
D02768
| - | - | 1件: 46 46 |
429 | Adempas | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 5件: 51 51, 86, 88, 225, 299 |
430 | Adempas (active agent riociguat) | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 88 |
431 | Adempas (Riociguat, BAY63-2521) | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 88 |
432 | ADEMPAS - 0,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
433 | ADEMPAS - 1 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 |
434 | ADEMPAS - 1,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 |
435 | ADEMPAS - 2 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 |
436 | ADEMPAS - 2,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 |
437 | Adempas 0.125 mg | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
438 | Adempas 0.5 mg | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 299 |
439 | Adempas 0.5 mg Film Coated Tablet | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
440 | Adempas 1 mg Film Coated Tablet | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
441 | Adempas 1.0 mg | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 299 |
442 | Adempas 1.5 mg | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
443 | Adempas 1.5 mg Film Coated Tablet | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
444 | Adempas 2 mg Film Coated Tablet | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
445 | Adempas 2.0 mg | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 299 |
446 | Adempas 2.5 mg | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
447 | Adempas 2.5 mg Film Coated Tablet | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
448 | Adempas® | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 88 |
449 | Adempas® 0.5 mg film-coated tablets | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
450 | Adempas® 1.0 mg film-coated tablets | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
451 | Adempas® 1.5 mg film-coated tablets | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
452 | Adempas® 2.0 mg film-coated tablets | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
453 | Adempas® 2.5 mg film-coated tablets | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
454 | Adempas¿ 0.5 mg compressa rivestita con film | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
455 | Adempas¿ 1.0 | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
456 | Adempas¿ 1.5 mg | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
457 | Adempas¿ 2.0 mg | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
458 | Adempas¿ 2.5 mg | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
459 | Adenin | 1件: Adenine Adenine | 1件: D00034
D00034
| - | - | 1件: 46 46 |
460 | ADENO-ASSOCIATED VIRAL (AAV) SEROTYPE 8 (AAV2/8) VECTOR WITH LIVER-SPECIFIC THYROXINE-BINDING GLOBULIN (TBG) PROMOTER, DRIVING THE EXPRESSION OF THE HUMAN ARSB GENE | 1件: Levothyroxine Levothyroxine | 2件: D01010
D01010
,
D08125
| 2件: THRA THRA, THRB 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | 1件: 19 19 |
461 | Adeno-associated viral vector serotype 3B encoding shortened human ATP7B | - | - | - | - | 1件: 171 171 |
462 | Adeno-associated viral vector serotype 8 containing the human MD1 gene | - | - | - | - | 1件: 113 113 |
463 | Adeno-associated viral vector serotype 9 containing the human mini-dystrophin gene | - | - | - | - | 1件: 113 113 |
464 | Adeno-associated viral vector serotype 9 containing the human N-acetyl-alpha-glucosaminidase gene | - | - | - | - | 1件: 19 19 |
465 | Adeno-associated viral vector serotype 9 encoding human ATP7B | - | - | - | - | 1件: 171 171 |
466 | Adeno-associated virus (AAV) serotype rh.10 expressing human betagalactosidase (AAVrh.10-CAG-betagal) | - | - | - | - | 1件: 19 19 |
467 | Adeno-associated virus (AAV) serotype rh.10 expressing human betagalactosidase (AAVrh.10-CAG-ßgal) | - | - | - | - | 1件: 19 19 |
468 | Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase A cDNA | 1件: Agalsidase alfa Agalsidase alfa | 1件: D02784
D02784
| 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 |
469 | Adeno-associated virus serotype 2/6 encoding Human Iduronate 2-sulfatase (hIDS) gene donor vector, SB-A6P-HNT Donor Vector | 1件: Idursulfase Idursulfase | 1件: D04499
D04499
| 1件: IDS IDS 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 1件: 19 19 |
470 | Adeno-associated virus serotype 2/6 encoding human iduronidase (hIDUA) gene donor vector, SB-A6P-HRL Donor Vector | - | - | - | - | 1件: 19 19 |
471 | Adeno-associated virus serotype 2/6 encoding Left side-zinc finger nuclease (ZFN1), SB-A6P-ZLEFT Vector | - | - | - | - | 1件: 19 19 |
472 | Adeno-associated virus serotype 2/6 encoding Right side-zinc finger nuclease (ZFN2), SB-A6P-ZRIGHT Vector | - | - | - | - | 1件: 19 19 |
473 | ADENO-ASSOCIATED VIRUS SEROTYPE 5 ENCODING A MICRORNA TARGETED TO HUMAN HUNTINGTIN GENE | - | - | - | - | 1件: 8 8 |
474 | Adeno-associated virus serotype 9 carrying the human fukutin-related protein and target sequence of the miR-208a | - | - | - | - | 1件: 113 113 |
475 | Adeno-associated virus serotype hu68 containing the human GALC gene | - | - | - | - | 1件: 19 19 |
476 | Adeno-associated virus serotype rh.10 expressing beta-galactosidase | 1件: Tilactase Tilactase | 1件: D03348
D03348
| - | - | 1件: 19 19 |
477 | ADENO-ASSOCIATED VIRUS SEROTYPE RH74 CONTAINING THE HUMAN MICRO-DYSTROPHIN GENE | - | - | - | - | 1件: 113 113 |
478 | Adeno-associated virus type 2 vector encoding Rab escort protein 1 | - | - | - | - | 1件: 90 90 |
479 | Adeno-associated virus-CFTR vector | - | - | - | - | 1件: 299 299 |
480 | Adenosine | 1件: Adenosine Adenosine | 1件: D00045
D00045
| 4件: ADORA1 ADORA1, ADORA2A, ADORA2B, ADORA3 💬 | 12件: Alcoholism Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 13 13, 58, 65 |
481 | Adipate | 1件: Iron (III) oxide adipate Iron (III) oxide adipate | - | - | - | 2件: 97 97, 228 |
482 | Adipose derived mesenchymal stem cell | - | - | - | - | 1件: 3 3 |
483 | Adipose derived mesenchymal stem cells | - | - | - | - | 1件: 86 86 |
484 | Adipose derived mesenchymal stem cells ( AD-MSCs) | - | - | - | - | 1件: 60 60 |
485 | Adipose derived stromal cells intravenously injected | - | - | - | - | 1件: 39 39 |
486 | Adipose derived, autologous mesenchymal stem cells | - | - | - | - | 1件: 97 97 |
487 | Adipose tissue harvest | - | - | - | - | 1件: 51 51 |
488 | Adipose tissue-derived mesenchymal stem cells | - | - | - | - | 1件: 97 97 |
489 | Adipose-cord mesenchymal stromal cells (A-MSCs) | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 97 97 |
490 | Adjunctive analgesics | - | - | - | - | 1件: 70 70 |
491 | Adjunctive anti-depressants | - | - | - | - | 1件: 70 70 |
492 | Adjuvant without active component | - | - | - | - | 2件: 6 6, 17 |
493 | ADL5859 | 1件: ADL5859 ADL5859 | - | - | - | 1件: 46 46 |
494 | ADMINISTRATION | - | - | - | - | 1件: 19 19 |
495 | Administration Kit | - | - | - | - | 1件: 19 19 |
496 | Administration of a high dose of desipramine | 1件: Desipramine Desipramine | 2件: D00812
D00812
,
D07791
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 156 156 |
497 | Administration of a low dose of desipramine | 1件: Desipramine Desipramine | 2件: D00812
D00812
,
D07791
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 156 156 |
498 | Administration of an ACE-inhibitor or not | - | - | - | - | 1件: 210 210 |
499 | Administration of Cimzia® | 1件: Certolizumab pegol Certolizumab pegol | 1件: D03441
D03441
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
500 | Administration of drug (Interferon-gamma 1-b) subcutaneously | - | - | - | - | 1件: 65 65 |
501 | Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil | 4件: Methylprednisolone Methylprednisolone, Mycophenolate mofetil, Mycophenolic acid, Prednisone | 11件: D00407
D00407
,
D00473
,
D00751
,
D00752
,
D00979
,
D05000
,
D05001
,
D05002
,
D05094
,
D05095
,
D05096
| 3件: IMPDH1 IMPDH1, IMPDH2, NR3C1 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | 1件: 49 49 |
502 | Administration of methylprednisolone, paracetamol and dexchlorpheniramine | 3件: Acetaminophen Acetaminophen, Dexchlorpheniramine, Methylprednisolone | 8件: D00217
D00217
,
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
,
D07803
| 4件: HRH1 HRH1, NR3C1, PTGS1, PTGS2 💬 | 26件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 49 49 |
503 | Administration of rituximab and methylprednisolone | 2件: Methylprednisolone Methylprednisolone, Rituximab | 7件: D00407
D00407
,
D00751
,
D00979
,
D02994
,
D05000
,
D05001
,
D05002
| 2件: MS4A1 MS4A1, NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 51 51 |
504 | Administration of stable isotope-labelled leucine- | 1件: Leucine Leucine | 1件: D00030
D00030
| - | - | 1件: 6 6 |
505 | Adoport | - | - | - | - | 1件: 222 222 |
506 | Adrabetadex | 1件: Adrabetadex Adrabetadex | - | - | - | 1件: 19 19 |
507 | Adrenal cortical hormone | - | - | - | - | 1件: 224 224 |
508 | Adrenalina | - | - | - | - | 1件: 299 299 |
509 | Adrenergic receptor binder (ARB) | - | - | - | - | 1件: 224 224 |
510 | Adrenocorticotrophic hormone ACTH | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 222 222 |
511 | Adrenocorticotropic Hormone | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 3件: 13 13, 50, 84 |
512 | Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®) | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 13 13 |
513 | Adrenocorticotropic Hormone Gel | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 50 50 |
514 | Adrenocorticotropin hormone | - | - | - | - | 1件: 145 145 |
515 | ADS-001 | - | - | - | - | 1件: 231 231 |
516 | ADS-5102 | - | - | - | - | 2件: 6 6, 13 |
517 | ADS-5102 (extended release amantadine HCl) | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
518 | ADS-5102, 137 mg | - | - | - | - | 1件: 13 13 |
519 | ADS-5102, 274 mg | - | - | - | - | 1件: 13 13 |
520 | ADSVF | - | - | - | - | 2件: 15 15, 96 |
521 | ADSVF application in the right hand | - | - | - | - | 1件: 51 51 |
522 | Adult human mesenchymal stem cells | 1件: Remestemcel-L Remestemcel-L | 1件: D09719
D09719
| - | - | 2件: 85 85, 96 |
523 | Advagraf 0,5mg | 1件: Tacrolimus Tacrolimus | 2件: D00107
D00107
,
D08556
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 |
524 | Advagraf 1mg | 1件: Tacrolimus Tacrolimus | 2件: D00107
D00107
,
D08556
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 |
525 | Advagraf 5mg | 1件: Tacrolimus Tacrolimus | 2件: D00107
D00107
,
D08556
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 |
526 | Advagraf prolonged-release hard capsules | 2件: Manganese citrate Manganese citrate, Tacrolimus | 2件: D00107
D00107
,
D08556
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
527 | ADVATE | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: D02958
D02958
| - | - | 1件: 288 288 |
528 | ADVATE (rAHF - PFM) | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: D02958
D02958
| - | - | 1件: 288 288 |
529 | ADVATE (rAHF-PFM) | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: D02958
D02958
| - | - | 1件: 288 288 |
530 | ADVATE 1000 IU powder and solvent for solution for injection | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: D02958
D02958
| - | - | 1件: 288 288 |
531 | ADVATE 1000IU powder and solvent for solution for injection | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: D02958
D02958
| - | - | 1件: 288 288 |
532 | ADVATE 500 IU powder and solvent for solution for injection | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: D02958
D02958
| - | - | 1件: 288 288 |
533 | Adverse Reactions of Gammagard subcutaneously at Week 12 | - | - | - | - | 1件: 65 65 |
534 | Adverse Reactions of Gammagard subcutaneously at Week 24 | - | - | - | - | 1件: 65 65 |
535 | Adverse Reactions of Gammagard subcutaneously at Week 36 | - | - | - | - | 1件: 65 65 |
536 | Adverse Reactions of Gammagard subdermally at Week 12 | - | - | - | - | 1件: 65 65 |
537 | Adverse Reactions of Gammagard subdermally at Week 24 | - | - | - | - | 1件: 65 65 |
538 | Adverse Reactions of Gammagard subdermally at Week 36 | - | - | - | - | 1件: 65 65 |
539 | ADX-102 1% Topical Dermal Cream (reproxalap) | 1件: Reproxalap Reproxalap | 1件: D11309
D11309
| - | - | 1件: 160 160 |
540 | ADX48621 | - | - | - | - | 1件: 6 6 |
541 | AEB071 | - | - | - | - | 1件: 97 97 |
542 | AEB071A | - | - | - | - | 1件: 97 97 |
543 | AED | - | - | - | - | 1件: 158 158 |
544 | AEGR-733 | - | - | - | - | 1件: 79 79 |
545 | AER-901 Solution for Nebulization | - | - | - | - | 1件: 86 86 |
546 | AER002 | - | - | - | - | 1件: 299 299 |
547 | Aerolised Liposomal Ciclosporin A | 1件: Cyclosporine Cyclosporine | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 |
548 | Aerolised Liposomal Ciclosporin A 10mg | 1件: Cyclosporine Cyclosporine | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 |
549 | Aerolised Liposomal Ciclosporin A 5mg | 1件: Cyclosporine Cyclosporine | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 |
550 | Aeroquin | - | - | - | - | 1件: 299 299 |
551 | Aerosol interferon-gamma | - | - | - | - | 1件: 85 85 |
552 | Aerosolized human Alpha-1 Antitrypsin | - | - | - | - | 1件: 231 231 |
553 | Aerosolized iloprost | 1件: Iloprost Iloprost | 1件: D02721
D02721
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
554 | Aerosolized, human, plasma-derived Alpha-1 Antitrypsin | - | - | - | - | 1件: 299 299 |
555 | Aerosoltherapy | - | - | - | - | 1件: 299 299 |
556 | AeroVanc | - | - | - | - | 1件: 299 299 |
557 | AERT, (R)-Baclofen | 1件: Baclofen Baclofen | 1件: D00241
D00241
| 2件: GABBR1 GABBR1, GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 |
558 | Aesculus Hippocastanum / Horse Chestnut | 1件: Horse chestnut Horse chestnut | 1件: D12028
D12028
| - | - | 1件: 210 210 |
559 | AEZS-130 | - | - | - | - | 1件: 78 78 |
560 | AEZS-130 (formerly ARD-07) | - | - | - | - | 1件: 78 78 |
561 | AF056 | - | - | - | - | 1件: 206 206 |
562 | AF37702 Injection | - | - | - | - | 1件: 283 283 |
563 | AF37702, Hematide | 1件: Peginesatide Peginesatide | 1件: D09946
D09946
| 1件: EPOR EPOR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 283 283 |
564 | AFAMELANOTIDE | 1件: Afamelanotide Afamelanotide | 1件: D10511
D10511
| 1件: MC1R MC1R 💬 | 2件: Melanogenesis Melanogenesis, Neuroactive ligand-receptor interaction 💬 | 2件: 159 159, 254 |
565 | Afamelanotide (16 mg implant) | 1件: Afamelanotide Afamelanotide | 1件: D10511
D10511
| 1件: MC1R MC1R 💬 | 2件: Melanogenesis Melanogenesis, Neuroactive ligand-receptor interaction 💬 | 1件: 159 159 |
566 | Afamelanotide Implant | 1件: Afamelanotide Afamelanotide | 1件: D10511
D10511
| 1件: MC1R MC1R 💬 | 2件: Melanogenesis Melanogenesis, Neuroactive ligand-receptor interaction 💬 | 1件: 254 254 |
567 | Afegostat | 1件: Afegostat Afegostat | 1件: D09576
D09576
| - | - | 1件: 19 19 |
568 | Afegostat tartrate | 1件: Afegostat Afegostat | 1件: D09576
D09576
| - | - | 1件: 19 19 |
569 | AFFITOPE® PD01A | - | - | - | - | 1件: 6 6 |
570 | AFFITOPE® PD01A + Adjuvant | - | - | - | - | 2件: 6 6, 17 |
571 | AFFITOPE® PD03A + Adjuvant | - | - | - | - | 1件: 17 17 |
572 | Afinitor | 1件: Everolimus Everolimus | 1件: D02714
D02714
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 3件: 34 34, 89, 158 |
573 | Afinitor (everolimus) | 1件: Everolimus Everolimus | 1件: D02714
D02714
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 137 137 |
574 | Afinitor 5mg Tablets | 1件: Everolimus Everolimus | 1件: D02714
D02714
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 2件: 89 89, 158 |
575 | Aflibercept | 1件: Aflibercept Aflibercept | 1件: D09574
D09574
| 3件: PGF PGF, VEGFA, VEGFB 💬 | 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 2件: 90 90, 166 |
576 | AFQ056 | - | - | - | - | 3件: 6 6, 8, 206 |
577 | AFQ056 with L-dopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
578 | AFQ065 | - | - | - | - | 1件: 6 6 |
579 | Afucosylated IgG1 kappa monoclonal antibody | - | - | - | - | 1件: 300 300 |
580 | AG011 | - | - | - | - | 1件: 97 97 |
581 | AG011 - Capsules | - | - | - | - | 1件: 97 97 |
582 | AG011 - Enema | - | - | - | - | 1件: 97 97 |
583 | AG10 | - | - | - | - | 1件: 28 28 |
584 | AG10 HCl | - | - | - | - | 1件: 28 28 |
585 | Agalsidase | - | - | - | - | 1件: 19 19 |
586 | AGALSIDASE ALFA | 1件: Agalsidase alfa Agalsidase alfa | 1件: D02784
D02784
| 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 |
587 | Agalsidase Alpha | 1件: Agalsidase alfa Agalsidase alfa | 1件: D02784
D02784
| 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 |
588 | AGALSIDASE BETA | 1件: Agalsidase beta Agalsidase beta | 1件: D03228
D03228
| 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 |
589 | Agalsidase beta (GZ419828) | 1件: Agalsidase beta Agalsidase beta | 1件: D03228
D03228
| 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 |
590 | Agalsidase beta (recombinant form) | 1件: Agalsidase beta Agalsidase beta | 1件: D03228
D03228
| 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 |
591 | AGALSIDASI ALFA | - | - | - | - | 1件: 19 19 |
592 | AGALSIDASI BETA | - | - | - | - | 1件: 19 19 |
593 | AGEE cream | - | - | - | - | 1件: 13 13 |
594 | AGLE 102 | - | - | - | - | 1件: 36 36 |
595 | AGM 719 | - | - | - | - | 1件: 46 46 |
596 | AGN 203818 | - | - | - | - | 1件: 226 226 |
597 | Agomelatine | 1件: Agomelatine Agomelatine | 1件: D02578
D02578
| 3件: HTR2C HTR2C, MTNR1A, MTNR1B 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 |
598 | Agomelatine or PIacebo | 1件: Agomelatine Agomelatine | 1件: D02578
D02578
| 3件: HTR2C HTR2C, MTNR1A, MTNR1B 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 |
599 | Agri-King Synbiotic (AKSB) | - | - | - | - | 1件: 96 96 |
600 | Agrippal S1 (Influenza vaccination) | - | - | - | - | 1件: 46 46 |
601 | AGS-009 | - | - | - | - | 1件: 49 49 |
602 | AGT-181 | - | - | - | - | 1件: 19 19 |
603 | AGT-181 (HIRMAb-IDUA) | - | - | - | - | 1件: 19 19 |
604 | AGT-182 | - | - | - | - | 1件: 19 19 |
605 | AGUA PARA PREPARACIONES INYECTABLES | - | - | - | - | 1件: 78 78 |
606 | AHA | - | - | - | - | 1件: 6 6 |
607 | AHA Exergame System | - | - | - | - | 1件: 6 6 |
608 | AHSC | - | - | - | - | 1件: 13 13 |
609 | AI-1000 G2 | - | - | - | - | 1件: 46 46 |
610 | AIDSVAX® B/E | - | - | - | - | 1件: 49 49 |
611 | AIMSPRO | - | - | - | - | 2件: 13 13, 51 |
612 | AIN | - | - | - | - | 1件: 13 13 |
613 | AIN457 | - | - | - | - | 8件: 13 13, 37, 41, 46, 56, 96, 107, 271 |
614 | AIN457, 150 mg | - | - | - | - | 1件: 271 271 |
615 | AIN457, 150mg | - | - | - | - | 1件: 37 37 |
616 | AIN457, 75 mg | - | - | - | - | 1件: 271 271 |
617 | AIN457A | - | - | - | - | 1件: 271 271 |
618 | AIN457F | - | - | - | - | 3件: 46 46, 107, 271 |
619 | Air | - | - | - | - | 8件: 3 3, 13, 51, 58, 85, 97, 193, 299 |
620 | AIR DNase | - | - | - | - | 1件: 299 299 |
621 | AIR DNase™ | - | - | - | - | 1件: 299 299 |
622 | Air filled balloon catheter | - | - | - | - | 1件: 51 51 |
623 | Air stacking manuever | - | - | - | - | 1件: 3 3 |
624 | AIR001 | - | - | - | - | 1件: 86 86 |
625 | AIR001 (sodium nitrite inhalation solution) | 1件: Nitrite Nitrite | - | - | - | 1件: 86 86 |
626 | AIR001 Inhalation Solution | - | - | - | - | 1件: 86 86 |
627 | AIR001 Inhalation Solution (Expansion arm) | - | - | - | - | 1件: 86 86 |
628 | Airway clearance technique | - | - | - | - | 1件: 299 299 |
629 | AJG501 | - | - | - | - | 1件: 97 97 |
630 | AJG511 | - | - | - | - | 1件: 97 97 |
631 | AJM300 | - | - | - | - | 1件: 97 97 |
632 | Ajulemic acid | 1件: Ajulemic acid Ajulemic acid | 1件: D11312
D11312
| 1件: CNR2 CNR2 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 50 50, 51, 299 |
633 | AK002 | - | - | - | - | 1件: 98 98 |
634 | AK102 | - | - | - | - | 1件: 79 79 |
635 | AK106-001616 | 1件: AK106-001616 AK106-001616 | - | - | - | 1件: 46 46 |
636 | AK1320 MS | - | - | - | - | 1件: 70 70 |
637 | AKBM-3031 | - | - | - | - | 1件: 49 49 |
638 | AKCEA-ANGPTL3-LRX | - | - | - | - | 2件: 79 79, 265 |
639 | Aknemin | - | - | - | - | 1件: 201 201 |
640 | Aknemin 50 | - | - | - | - | 1件: 201 201 |
641 | AKR-501, YM-477 | - | - | - | - | 1件: 63 63 |
642 | AKST4290 | - | - | - | - | 2件: 6 6, 162 |
643 | AL | - | - | - | - | 10件: 5 5, 7, 13, 28, 51, 67, 86, 97, 114, 127 |
644 | AL-108 | - | - | - | - | 1件: 5 5 |
645 | AL001 | - | - | - | - | 2件: 2 2, 127 |
646 | AL01211 | - | - | - | - | 1件: 67 67 |
647 | AL2846 capsules | - | - | - | - | 1件: 34 34 |
648 | ALA | - | - | - | - | 1件: 286 286 |
649 | Alanine | 1件: Alanine Alanine | 1件: D00012
D00012
| - | - | 5件: 6 6, 13, 251, 298, 299 |
650 | Albendazole | 1件: Albendazole Albendazole | 1件: D00134
D00134
| - | - | 1件: 96 96 |
651 | Albendazole (Eskazole) | 1件: Albendazole Albendazole | 1件: D00134
D00134
| - | - | 1件: 96 96 |
652 | Albumen | 1件: Egg white Egg white | - | - | - | 1件: 96 96 |
653 | Albumin | - | - | - | - | 3件: 2 2, 20, 51 |
654 | Albumin (Human) 20%, United States Pharmacopeia (USP) | - | - | - | - | 1件: 231 231 |
655 | Albumin (Human) 25%, United States Pharmacopeia (USP) | - | - | - | - | 2件: 13 13, 14 |
656 | Albumin solution | - | - | - | - | 1件: 20 20 |
657 | ALBUMINE HUMAINE | - | - | - | - | 1件: 96 96 |
658 | Albunorm® 5%, | - | - | - | - | 1件: 20 20 |
659 | Albutein 5% | - | - | - | - | 1件: 2 2 |
660 | Albuterol | 1件: Salbutamol Salbutamol | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 12 12, 13, 86, 89, 113, 231, 256, 299 |
661 | Albuterol inhaler | 1件: Salbutamol Salbutamol | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 89 89 |
662 | Albuterol inhaler. | 1件: Salbutamol Salbutamol | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 231 231, 299 |
663 | Albuterol nebulizer | 1件: Salbutamol Salbutamol | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 89 89 |
664 | Albuterol. | 1件: Salbutamol Salbutamol | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
665 | Albutropin | - | - | - | - | 1件: 78 78 |
666 | Albúmina humana | - | - | - | - | 1件: 2 2 |
667 | Alcohol | 1件: Ethanol Ethanol | 4件: D00068
D00068
,
D02798
,
D04855
,
D06542
| - | - | 4件: 13 13, 58, 279, 298 |
668 | Alcohol Septal Ablation | 1件: Ethanol Ethanol | 4件: D00068
D00068
,
D02798
,
D04855
,
D06542
| - | - | 1件: 58 58 |
669 | Alcohol Wipes vs. No Alcohol Wipes | 1件: Ethanol Ethanol | 4件: D00068
D00068
,
D02798
,
D04855
,
D06542
| - | - | 1件: 13 13 |
670 | ALD518 | - | - | - | - | 1件: 46 46 |
671 | ALD518 monoclonal antibody (anti IL-6 mAb) | - | - | - | - | 1件: 46 46 |
672 | ALDESLEUCHINA | - | - | - | - | 1件: 49 49 |
673 | ALDESLEUKIN | 1件: Aldesleukin Aldesleukin | 1件: D00748
D00748
| 3件: IL2RA IL2RA, IL2RB, IL2RG 💬 | 14件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | 4件: 49 49, 65, 96, 97 |
674 | Aldosterone | 1件: Aldosterone Aldosterone | 1件: D10528
D10528
| 1件: NR3C2 NR3C2 💬 | 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 1件: 222 222 |
675 | Aldurazyme | 1件: Laronidase Laronidase | 1件: D04670
D04670
| 1件: IDUA IDUA 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 1件: 19 19 |
676 | Aldurazyme (laronidase) | 1件: Laronidase Laronidase | 1件: D04670
D04670
| 1件: IDUA IDUA 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 2件: 19 19, 256 |
677 | Aldurazyme (Recombinant Human Alpha-L-Iduronidase) | 1件: Laronidase Laronidase | 1件: D04670
D04670
| 1件: IDUA IDUA 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 1件: 19 19 |
678 | ALDURAZYME*INFUS 1FL 5ML 500U | 1件: Laronidase Laronidase | 1件: D04670
D04670
| 1件: IDUA IDUA 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 1件: 19 19 |
679 | Alefacept | 1件: Alefacept Alefacept | 1件: D02800
D02800
| 1件: CD58 CD58 💬 | 2件: Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection 💬 | 6件: 37 37, 60, 65, 164, 284, 285 |
680 | ALEMTUZUMAB | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 17件: 13 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 |
681 | Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994 | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 1件: 46 46 |
682 | Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994) | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 1件: 46 46 |
683 | Alemtuzumab (Campath ) | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 1件: 60 60 |
684 | Alemtuzumab (Campath) | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 1件: 15 15 |
685 | Alemtuzumab (GZ402673) | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 1件: 13 13 |
686 | Alemtuzumab 0.2 mg | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 2件: 65 65, 164 |
687 | Alemtuzumab 0.3 mg | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 2件: 65 65, 164 |
688 | Alemtuzumab 12 mg | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 1件: 13 13 |
689 | Alemtuzumab 24 mg | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 1件: 13 13 |
690 | Alemtuzumab and Rituximab | 2件: Alemtuzumab Alemtuzumab, Rituximab | 2件: D02802
D02802
,
D02994
| 2件: CD52 CD52, MS4A1 💬 | - | 1件: 60 60 |
691 | Alemtuzumab GZ402673 | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 1件: 13 13 |
692 | Alemtuzumab immunotherapy | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 1件: 13 13 |
693 | Alemtuzumab Injection | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 1件: 13 13 |
694 | Alemtuzumab Injection [Lemtrada] | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 1件: 13 13 |
695 | Alemtuzumab, Rituximab | 2件: Alemtuzumab Alemtuzumab, Rituximab | 2件: D02802
D02802
,
D02994
| 2件: CD52 CD52, MS4A1 💬 | - | 1件: 63 63 |
696 | Alendronat Teva | - | - | - | - | 1件: 46 46 |
697 | Alendronate | 1件: Alendronic acid Alendronic acid | 2件: D00939
D00939
,
D07119
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 7件: 19 19, 41, 46, 50, 271, 274, 299 |
698 | Alendronate sodium | 1件: Alendronic acid Alendronic acid | 2件: D00939
D00939
,
D07119
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 2件: 19 19, 299 |
699 | Alendronate versus alfacalcidol (1-alpha OH vitamin D) | 3件: Alendronic acid Alendronic acid, Alfacalcidol, Vitamin D | 3件: D00939
D00939
,
D01518
,
D07119
| 2件: FDPS FDPS, VDR 💬 | 9件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis 💬 | 3件: 41 41, 46, 50 |
700 | ALENDRONIC ACID | 1件: Alendronic acid Alendronic acid | 2件: D00939
D00939
,
D07119
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 2件: 46 46, 274 |
701 | Alentuzumab (Campath) | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 1件: 65 65 |
702 | Alequel | - | - | - | - | 1件: 96 96 |
703 | Alfa-manosidadas humana recombinante | - | - | - | - | 1件: 19 19 |
704 | Alfacalcidol | 1件: Alfacalcidol Alfacalcidol | 1件: D01518
D01518
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 8件: 41 41, 46, 49, 50, 96, 107, 235, 238 |
705 | Alfacalcidol 2 micrograms/ml | 1件: Alfacalcidol Alfacalcidol | 1件: D01518
D01518
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 2件: 50 50, 107 |
706 | Alfuzosin | 1件: Alfuzosin Alfuzosin | 2件: D01692
D01692
,
D07124
| 1件: ADRA1A ADRA1A 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 13 13 |
707 | Alga Dunaliella Bardawil | - | - | - | - | 1件: 90 90 |
708 | Alga Dunaliella Bardawil powder | - | - | - | - | 1件: 90 90 |
709 | Alga Dunaliella Bardawill | - | - | - | - | 1件: 90 90 |
710 | Algin | 1件: Alginic acid Alginic acid | 1件: D02324
D02324
| - | - | 1件: 97 97 |
711 | Alginate | 1件: Alginic acid Alginic acid | 1件: D02324
D02324
| - | - | 2件: 53 53, 299 |
712 | Alginate oligosaccharide | 1件: Alginic acid Alginic acid | 1件: D02324
D02324
| - | - | 1件: 299 299 |
713 | Alginic acid | 1件: Alginic acid Alginic acid | 1件: D02324
D02324
| - | - | 1件: 51 51 |
714 | ALGLUCOSIDASE ALFA | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: D03207
D03207
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
715 | Alglucosidase Alfa (Genetical Recombination) | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: D03207
D03207
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
716 | Alglucosidase alfa (GZ419829) | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: D03207
D03207
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
717 | ALGLUCOSIDASE ALFA (MYOZYME) | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: D03207
D03207
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
718 | Alglucosidase alfa (recombinant human acid alpha-glucosidase [rhGAA]) | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: D03207
D03207
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
719 | Alglucosidase alfa GZ419829 | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: D03207
D03207
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
720 | Alglucosidase alfa GZ419829 (Myozyme) | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: D03207
D03207
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
721 | Alglucosidase alpha | - | - | - | - | 1件: 256 256 |
722 | ALGLUCOSIDASI ALFA UMANA RICOMBINANTE | - | - | - | - | 1件: 256 256 |
723 | Alicaforsen | 1件: Alicaforsen Alicaforsen | - | - | - | 2件: 96 96, 97 |
724 | Alicalm (polymeric liquid formula) | - | - | - | - | 1件: 96 96 |
725 | ALIROCUMAB | 1件: Alirocumab Alirocumab | 1件: D10335
D10335
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
726 | Alirocumab SAR236553 (REGN727) | 1件: Alirocumab Alirocumab | 1件: D10335
D10335
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
727 | Aliskiren | 1件: Aliskiren Aliskiren | 1件: D03208
D03208
| 1件: REN REN 💬 | 3件: Diabetic cardiomyopathy Diabetic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 3件: 66 66, 167, 222 |
728 | ALITRETINOIN | 1件: Alitretinoin Alitretinoin | 1件: D02815
D02815
| 5件: RARA RARA, RARB, RXRA, RXRB, RXRG 💬 | 19件: Acute myeloid leukemia Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬 | 1件: 49 49 |
729 | ALK-001 | - | - | - | - | 1件: 301 301 |
730 | ALK-001 (No generic name) | - | - | - | - | 1件: 301 301 |
731 | Alkaline Phosphatase | 1件: Alkaline Phosphatase Alkaline Phosphatase | - | - | - | 4件: 46 46, 93, 97, 172 |
732 | Alkalinized Lidocaine-Heparin | 2件: Heparin Heparin, Lidocaine | 4件: D00358
D00358
,
D02086
,
D07510
,
D08127
| 6件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 | 4件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 💬 | 1件: 226 226 |
733 | ALKERAN | 1件: Melphalan Melphalan | 1件: D00369
D00369
| - | - | 2件: 28 28, 60 |
734 | ALKS 8700 | - | - | - | - | 1件: 13 13 |
735 | ALKS 8700 Delayed Release (DR) | 1件: Manganese citrate Manganese citrate | - | - | - | 1件: 13 13 |
736 | ALKS 8700 Delayed Release (DR) Capsule | 1件: Manganese citrate Manganese citrate | - | - | - | 1件: 13 13 |
737 | All patients in the study will be treated with ocrelizumab | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
738 | All subjects will receive maraviroc 300mg orally twice a day for 6 weeks | 1件: Maraviroc Maraviroc | 1件: D06670
D06670
| 1件: CCR5 CCR5 💬 | 9件: Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 84 84 |
739 | All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-P-thioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidine | - | - | - | - | 1件: 2 2 |
740 | All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-Pthioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy- | - | - | - | - | 1件: 2 2 |
741 | All-trans retinoic acid | 1件: Tretinoin Tretinoin | 1件: D00094
D00094
| 3件: PML PML, RARA, RARB 💬 | 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 94 94 |
742 | All-Trans Retinoid Acid(ATRA) | 1件: Tretinoin Tretinoin | 1件: D00094
D00094
| 3件: PML PML, RARA, RARB 💬 | 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 63 63 |
743 | ALLANTOIN | 1件: Allantoin Allantoin | 1件: D00121
D00121
| - | - | 1件: 36 36 |
744 | ALLANTOINA | - | - | - | - | 1件: 36 36 |
745 | Allergen | - | - | - | - | 1件: 98 98 |
746 | Allergy immunotherapy (allergy shots) | - | - | - | - | 1件: 98 98 |
747 | Allo BMT | - | - | - | - | 1件: 65 65 |
748 | Allo-APZ2-EB | - | - | - | - | 1件: 36 36 |
749 | ALLO-ASC | - | - | - | - | 1件: 96 96 |
750 | ALLO-ASC-CD | - | - | - | - | 1件: 96 96 |
751 | ALLO-ASC-DFU | - | - | - | - | 1件: 36 36 |
752 | Allo-hMSCs | - | - | - | - | 2件: 211 211, 299 |
753 | AlloGen-LI | - | - | - | - | 1件: 70 70 |
754 | Allogeneic adipose tissue-derived mesenchymal stem cells | - | - | - | - | 1件: 97 97 |
755 | ALLOGENEIC ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS EXPANDED | - | - | - | - | 2件: 36 36, 53 |
756 | Allogeneic adipose tissue-derived MSC | - | - | - | - | 1件: 36 36 |
757 | Allogeneic adipose tissue-derived stromal/stem cells | - | - | - | - | 1件: 53 53 |
758 | Allogeneic Adult Human Mesenchymal Stem Cells (hMSCs) | 1件: Remestemcel-L Remestemcel-L | 1件: D09719
D09719
| - | - | 1件: 85 85 |
759 | Allogeneic Bone Marrow derived Human Mesenchymal Stem Cells (hMSCs) | - | - | - | - | 1件: 96 96 |
760 | Allogeneic bone marrow transplant | - | - | - | - | 1件: 49 49 |
761 | Allogeneic Bone Marrow Transplantation | - | - | - | - | 9件: 60 60, 62, 65, 96, 164, 283, 284, 285, 286 |
762 | Allogeneic bone marrow-derived MSCs (1 x 10 6 MSC/kg) | - | - | - | - | 1件: 6 6 |
763 | Allogeneic bone marrow-derived MSCs (10 x 10 6 MSC/kg) | - | - | - | - | 1件: 6 6 |
764 | Allogeneic bone marrow-derived MSCs (3 x 10 6 MSC/kg) | - | - | - | - | 1件: 6 6 |
765 | Allogeneic bone marrow-derived MSCs (6 x 10 6 MSC/kg) | - | - | - | - | 1件: 6 6 |
766 | Allogeneic Cardiosphere-Derived Cells (CAP-1002) | 1件: CAP-1002 CAP-1002 | - | - | - | 1件: 113 113 |
767 | Allogeneic donor derived B-lymphocytes | - | - | - | - | 1件: 60 60 |
768 | Allogeneic fecal microbiota | - | - | - | - | 1件: 13 13 |
769 | Allogeneic hematopoietic stem cell transplantation | - | - | - | - | 8件: 28 28, 51, 60, 62, 65, 164, 284, 285 |
770 | Allogeneic HSC | - | - | - | - | 1件: 65 65 |
771 | Allogeneic HSCT | - | - | - | - | 1件: 65 65 |
772 | Allogeneic Human Cardiosphere-Derived Stem Cells | - | - | - | - | 1件: 86 86 |
773 | Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells | - | - | - | - | 1件: 13 13 |
774 | ALLOGENEIC MESENCHYMAL PRECURSOR CELLS | - | - | - | - | 1件: 46 46 |
775 | Allogeneic Mesenchymal Stem Cells | - | - | - | - | 1件: 47 47 |
776 | Allogeneic Mesenchymal Stem Cells (AlloMSC) | - | - | - | - | 2件: 51 51, 53 |
777 | Allogeneic mesenchymal stromal cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 36 36 |
778 | ALLOGENEIC MESENCHYMAL STROMAL CELLS DERIVED FROM THE UMBILICAL CORD | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 49 49 |
779 | Allogeneic MSC (AlloMSC) | - | - | - | - | 1件: 49 49 |
780 | ALLOGENEIC NEURAL RETINA-DERIVED HUMAN NEURAL RETINAL PROGENITOR CELLS EX VIVO EXPANDED | - | - | - | - | 1件: 90 90 |
781 | Allogeneic peripheral blood stem cell | - | - | - | - | 1件: 65 65 |
782 | Allogeneic skin-derived ABCB5-positive mesenchymal stem cells | - | - | - | - | 1件: 36 36 |
783 | Allogeneic Stem Cell Therapy | - | - | - | - | 1件: 96 96 |
784 | Allogeneic Stem Cell Transplant | - | - | - | - | 3件: 53 53, 56, 60 |
785 | Allogeneic stem cell transplantation | - | - | - | - | 5件: 19 19, 20, 49, 62, 84 |
786 | Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation | - | - | - | - | 1件: 17 17 |
787 | Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation | - | - | - | - | 1件: 17 17 |
788 | Allogenic eASCs 5 milion cells/ml suspension for injection. Cx601 | - | - | - | - | 1件: 96 96 |
789 | Allogenic eASCs 5 million cells/ml suspension for injection CX601 | - | - | - | - | 1件: 96 96 |
790 | Allogenic eASCs 5 million cells/ml suspension for injection. CX601 | - | - | - | - | 1件: 96 96 |
791 | Allogenic eASCs 5 million/ml suspension for injection. | - | - | - | - | 1件: 96 96 |
792 | ALLOGENIC HUMAN HETEROLOGOUS LIVER CELLS | - | - | - | - | 1件: 251 251 |
793 | Allogenic mesenchymal stromal cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 36 36 |
794 | Allogenic parathyroid cells | - | - | - | - | 1件: 235 235 |
795 | Allogenic Stem Cell Transplantation | - | - | - | - | 1件: 60 60 |
796 | Allograft | - | - | - | - | 1件: 70 70 |
797 | Allopregnanolone | 1件: Brexanolone Brexanolone | 1件: D11149
D11149
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 205 205 |
798 | Allopurinol | 1件: Allopurinol Allopurinol | 1件: D00224
D00224
| 1件: XDH XDH 💬 | 5件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬 | 6件: 6 6, 46, 57, 66, 96, 97 |
799 | Allopurinol Sandoz 100 mg, tabletten | 1件: Allopurinol Allopurinol | 1件: D00224
D00224
| 1件: XDH XDH 💬 | 5件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬 | 1件: 96 96 |
800 | ALLOPURINOL SODIUM | 1件: Allopurinol Allopurinol | 1件: D00224
D00224
| 1件: XDH XDH 💬 | 5件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬 | 1件: 96 96 |
801 | AlloRx | - | - | - | - | 8件: 2 2, 6, 13, 46, 51, 85, 90, 226 |
802 | ALN-51547 | - | - | - | - | 1件: 28 28 |
803 | ALN-60212 | - | - | - | - | 1件: 79 79 |
804 | ALN-60519 | - | - | - | - | 1件: 254 254 |
805 | ALN-61444 | - | - | - | - | 1件: 231 231 |
806 | ALN-62643 | - | - | - | - | 2件: 62 62, 109 |
807 | ALN-65585 | - | - | - | - | 1件: 234 234 |
808 | ALN-77412 | - | - | - | - | 1件: 231 231 |
809 | ALN-AAT | - | - | - | - | 1件: 231 231 |
810 | ALN-AAT02 | - | - | - | - | 1件: 231 231 |
811 | ALN-AS1 | - | - | - | - | 1件: 254 254 |
812 | ALN-CC5 | - | - | - | - | 4件: 11 11, 62, 66, 109 |
813 | ALN-GO1 | - | - | - | - | 1件: 234 234 |
814 | ALN-PCSSC | 1件: Inclisiran Inclisiran | 1件: D11931
D11931
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
815 | ALN-TTRSC | - | - | - | - | 1件: 28 28 |
816 | AloASC | - | - | - | - | 1件: 97 97 |
817 | Aloe | 1件: Aloe vera leaf Aloe vera leaf | - | - | - | 2件: 97 97, 226 |
818 | Aloe Barbadensis Miller | 1件: Aloe vera leaf Aloe vera leaf | - | - | - | 1件: 97 97 |
819 | Aloe vera | 1件: Aloe vera leaf Aloe vera leaf | - | - | - | 3件: 53 53, 97, 226 |
820 | Aloe vera gel | 1件: Aloe vera leaf Aloe vera leaf | - | - | - | 1件: 97 97 |
821 | Alofisel | 1件: Darvadstrocel Darvadstrocel | 1件: D11397
D11397
| - | - | 1件: 96 96 |
822 | Alpha 1-Antitrypsin | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 2件: 231 231, 298 |
823 | Alpha 1-Proteinase Inhibitor | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 1件: 231 231 |
824 | Alpha 1-proteinase inhibitor (human) | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 1件: 231 231 |
825 | Alpha beta depletion | - | - | - | - | 2件: 60 60, 284 |
826 | Alpha interferon | - | - | - | - | 1件: 56 56 |
827 | Alpha Lipoic Acid | 1件: Lipoic acid Lipoic acid | 2件: D00048
D00048
,
D00086
| - | - | 1件: 13 13 |
828 | Alpha-1 Antitrypsin (AAT) | - | - | - | - | 1件: 231 231 |
829 | Alpha-1 Antitrypsin (human) | - | - | - | - | 1件: 231 231 |
830 | Alpha-1 HC 100 mg | - | - | - | - | 1件: 299 299 |
831 | Alpha-1 HC 200 mg | - | - | - | - | 1件: 299 299 |
832 | Alpha-1 MP | - | - | - | - | 1件: 231 231 |
833 | Alpha-1 proteinase inhibitor (human) | - | - | - | - | 1件: 231 231 |
834 | ALPHA-1-ANTITRYPSIN | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 1件: 231 231 |
835 | Alpha-2C AR antagonist | - | - | - | - | 1件: 51 51 |
836 | Alpha-galactosidase A | 1件: Agalsidase alfa Agalsidase alfa | 1件: D02784
D02784
| 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 |
837 | Alpha-glucosidase | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: D03207
D03207
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
838 | ALPHA-LIPOIC ACID | 1件: Lipoic acid Lipoic acid | 2件: D00048
D00048
,
D00086
| - | - | 2件: 2 2, 13 |
839 | Alpha-lipoic acid and L-acetyl carnitine | 2件: Levocarnitine Levocarnitine, Lipoic acid | 5件: D00048
D00048
,
D00086
,
D02030
,
D02176
,
D04713
| - | - | 1件: 5 5 |
840 | Alpha-tocopherol | 2件: Tocopherol Tocopherol, Vitamin E | 2件: D02331
D02331
,
D02332
| - | - | 2件: 49 49, 206 |
841 | Alpha-tocotrienol quinone | 1件: Tocotrienol Tocotrienol | - | - | - | 2件: 21 21, 156 |
842 | Alpha-tocotrienolquinone | - | - | - | - | 1件: 18 18 |
843 | Alpha1-antitrypsin | - | - | - | - | 1件: 13 13 |
844 | Alpha1-Proteinase Inhibitor | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 2件: 231 231, 299 |
845 | Alpha1-Proteinase Inhibitor (Human) | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 2件: 231 231, 299 |
846 | Alphanate | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
847 | Alphanate 1000 I.U. | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
848 | Alphanate 1500 I.U. | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
849 | Alphanate SD/HT | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
850 | ALPHANATE*INF 1F 1000UI+F 10ML | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
851 | ALPHANATE*INF 1F 1500UI+F 10ML | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
852 | ALPHANATE*INF 1F 250UI+F 5ML | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
853 | ALPHANATE*INF 1F 500UI+F 5ML | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
854 | ALPN-101 | - | - | - | - | 1件: 49 49 |
855 | Alprazolam | 1件: Alprazolam Alprazolam | 1件: D00225
D00225
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 2件: 8 8, 75 |
856 | Alprostadil | 1件: Alprostadil Alprostadil | 2件: D00180
D00180
,
D02705
| 1件: PTGER1 PTGER1 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer 💬 | 2件: 51 51, 70 |
857 | ALRN-5281 0.015 mg/kg | - | - | - | - | 1件: 78 78 |
858 | ALRN-5281 0.05 mg/kg | - | - | - | - | 1件: 78 78 |
859 | ALRN-5281 0.15 mg/kg | - | - | - | - | 1件: 78 78 |
860 | Also referred to as 'MEDI2070' | - | - | - | - | 2件: 96 96, 97 |
861 | Also referred to as MED2070 | - | - | - | - | 1件: 96 96 |
862 | Also referred to as MEDI2070 | - | - | - | - | 2件: 96 96, 97 |
863 | Alternating, 10 sec High-Frequency, 10 sec Low-Frequency Stimulation | - | - | - | - | 1件: 6 6 |
864 | Alternating, 10 sec High-Frequency, 50 sec Low-Frequency Stimulation | - | - | - | - | 1件: 6 6 |
865 | Alternating, 50 sec High-Frequency, 10 sec Low-Frequency Stimulation | - | - | - | - | 1件: 6 6 |
866 | Alternating, 50 sec High-Frequency, 50 sec Low-Frequency Stimulation | - | - | - | - | 1件: 6 6 |
867 | Alternative osteoporosis medications | - | - | - | - | 1件: 274 274 |
868 | ALTH12-1:4 | - | - | - | - | 1件: 97 97 |
869 | ALTH12-2:4 | - | - | - | - | 1件: 97 97 |
870 | ALTRI FARMACI DEL SISTEMA NERVOSO | - | - | - | - | 1件: 13 13 |
871 | Altropane | 1件: Altropane Altropane | - | - | - | 1件: 6 6 |
872 | ALTROPANE® | 1件: Altropane Altropane | - | - | - | 1件: 6 6 |
873 | ALTU-135 | 1件: ALTU-135 ALTU-135 | - | - | - | 1件: 299 299 |
874 | ALTU-238 | - | - | - | - | 1件: 78 78 |
875 | ALTUS-135 | - | - | - | - | 1件: 299 299 |
876 | Aluminium | 1件: Aluminium Aluminium | - | - | - | 2件: 11 11, 46 |
877 | Aluminium hydroxide | 3件: Aluminium Aluminium, Aluminum hydroxide, Hydroxide ion | 1件: D02416
D02416
| - | - | 2件: 11 11, 46 |
878 | Aluminium phosphate | 3件: Aluminium Aluminium, Aluminium phosphate, Phosphate ion | - | - | - | 1件: 46 46 |
879 | Aluminum | 1件: Aluminium Aluminium | - | - | - | 1件: 11 11 |
880 | Aluminum hydroxide | 3件: Aluminium Aluminium, Aluminum hydroxide, Hydroxide ion | 1件: D02416
D02416
| - | - | 1件: 11 11 |
881 | Alvarez 2 | - | - | - | - | 1件: 37 37 |
882 | ALVELESTAT | 1件: Alvelestat Alvelestat | - | - | - | 1件: 231 231 |
883 | Alvelestat (MPH966) | 1件: Alvelestat Alvelestat | - | - | - | 1件: 231 231 |
884 | Alvelestat oral tablet - dose 1 | 1件: Alvelestat Alvelestat | - | - | - | 1件: 231 231 |
885 | Alvelestat oral tablet - dose 2 | 1件: Alvelestat Alvelestat | - | - | - | 1件: 231 231 |
886 | Alvelestat tosylate | 1件: Alvelestat Alvelestat | - | - | - | 1件: 231 231 |
887 | Alwextin cream | - | - | - | - | 1件: 36 36 |
888 | ALX-0061 | - | - | - | - | 2件: 46 46, 49 |
889 | ALX-0061 150 mg/mL | - | - | - | - | 1件: 49 49 |
890 | ALX-0061 Nanobody | - | - | - | - | 1件: 46 46 |
891 | ALX-0081 | - | - | - | - | 1件: 64 64 |
892 | ALX-009 | - | - | - | - | 1件: 299 299 |
893 | ALX-0600 | - | - | - | - | 1件: 96 96 |
894 | ALXN1102 | - | - | - | - | 1件: 62 62 |
895 | ALXN1103 | - | - | - | - | 1件: 62 62 |
896 | ALXN1210 | - | - | - | - | 7件: 2 2, 11, 13, 50, 62, 66, 109 |
897 | ALXN1830 | - | - | - | - | 3件: 11 11, 35, 61 |
898 | ALXN1840 | - | - | - | - | 1件: 171 171 |
899 | ALXN1850 | - | - | - | - | 1件: 172 172 |
900 | ALXN2040 | - | - | - | - | 1件: 62 62 |
901 | ALXN2040 (ACH-0144471) | - | - | - | - | 1件: 62 62 |
902 | ALXN2050 | - | - | - | - | 2件: 11 11, 62 |
903 | ALZT-OP1a (cromolyn) | 1件: Cromoglicic acid Cromoglicic acid | 2件: D00526
D00526
,
D07753
| - | - | 1件: 2 2 |
904 | AM-01 | - | - | - | - | 1件: 51 51 |
905 | Amantadin-ratiopharm 100mg | - | - | - | - | 1件: 6 6 |
906 | AMANTADINE | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 4件: 6 6, 8, 13, 127 |
907 | Amantadine 300 mg | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
908 | Amantadine HCl ER | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
909 | Amantadine HCl Extended Release | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
910 | Amantadine HCl Extended Release Capsule | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
911 | AMANTADINE HYDROCHLORIDE | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
912 | Amantadine hydrochloride (HCl) | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
913 | Amantadine sulfate | 2件: Amantadine Amantadine, Sulfate ion | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
914 | Ambirix | - | - | - | - | 1件: 107 107 |
915 | Ambrisentan | 1件: Ambrisentan Ambrisentan | 1件: D07077
D07077
| 1件: EDNRA EDNRA 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 7件: 51 51, 84, 85, 86, 88, 210, 211 |
916 | Ambrisentan - high dose | 1件: Ambrisentan Ambrisentan | 1件: D07077
D07077
| 1件: EDNRA EDNRA 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
917 | Ambrisentan - low dose | 1件: Ambrisentan Ambrisentan | 1件: D07077
D07077
| 1件: EDNRA EDNRA 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
918 | Ambrisentan 5 mg | 1件: Ambrisentan Ambrisentan | 1件: D07077
D07077
| 1件: EDNRA EDNRA 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 88 88 |
919 | Ambrisentan 5 mg film-coated tablets | 1件: Ambrisentan Ambrisentan | 1件: D07077
D07077
| 1件: EDNRA EDNRA 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
920 | Ambrisentan 5mg film-coated tablets [marketed product] | 1件: Ambrisentan Ambrisentan | 1件: D07077
D07077
| 1件: EDNRA EDNRA 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
921 | Ambrisentan plus Spironolactone | 2件: Ambrisentan Ambrisentan, Spironolactone | 2件: D00443
D00443
,
D07077
| 2件: EDNRA EDNRA, NR3C2 💬 | 8件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
922 | Ambrisentan Tablet | 1件: Ambrisentan Ambrisentan | 1件: D07077
D07077
| 1件: EDNRA EDNRA 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
923 | AMBROSAN 60mg Tablets | - | - | - | - | 1件: 6 6 |
924 | Ambroxol | 1件: Ambroxol Ambroxol | 1件: D07442
D07442
| - | - | 2件: 6 6, 19 |
925 | Ambroxol Hydrochloride | 1件: Ambroxol Ambroxol | 1件: D07442
D07442
| - | - | 1件: 6 6 |
926 | AmCell CliniMACs | - | - | - | - | 1件: 285 285 |
927 | AMD3100 | - | - | - | - | 1件: 285 285 |
928 | American Ginseng | 2件: Ginseng Ginseng, Panax quinquefolius whole | 1件: D06772
D06772
| - | - | 1件: 13 13 |
929 | American ginseng extract HT-1001 | 2件: Ginseng Ginseng, Panax quinquefolius whole | 1件: D06772
D06772
| - | - | 1件: 13 13 |
930 | AMG 108 | 1件: AMG 108 AMG 108 | - | - | - | 1件: 46 46 |
931 | AMG 139 | - | - | - | - | 1件: 96 96 |
932 | AMG 145 | - | - | - | - | 1件: 79 79 |
933 | AMG 162 | - | - | - | - | 2件: 46 46, 274 |
934 | AMG 181 | - | - | - | - | 2件: 96 96, 97 |
935 | AMG 357 | - | - | - | - | 1件: 46 46 |
936 | AMG 407 | - | - | - | - | 1件: 56 56 |
937 | AMG 531 | - | - | - | - | 1件: 63 63 |
938 | AMG 557 | - | - | - | - | 1件: 49 49 |
939 | AMG 557/MEDI5872 | - | - | - | - | 1件: 53 53 |
940 | AMG 570 | - | - | - | - | 2件: 46 46, 49 |
941 | AMG 592 | - | - | - | - | 3件: 46 46, 49, 97 |
942 | AMG 623 | - | - | - | - | 1件: 49 49 |
943 | AMG 714 | - | - | - | - | 1件: 46 46 |
944 | AMG 719 | - | - | - | - | 1件: 46 46 |
945 | AMG 785 | - | - | - | - | 1件: 274 274 |
946 | AMG 811 | - | - | - | - | 1件: 49 49 |
947 | AMG 827 | - | - | - | - | 2件: 46 46, 96 |
948 | AMG 827 140 mg | - | - | - | - | 1件: 46 46 |
949 | AMG 827 210 mg | - | - | - | - | 2件: 46 46, 96 |
950 | AMG 827 350 MG | - | - | - | - | 1件: 96 96 |
951 | AMG 827 70 mg | - | - | - | - | 1件: 46 46 |
952 | AMG 827 700 MG | - | - | - | - | 1件: 96 96 |
953 | AMG-407 | - | - | - | - | 2件: 56 56, 107 |
954 | AMG145 | - | - | - | - | 1件: 79 79 |
955 | AMG181 | - | - | - | - | 1件: 97 97 |
956 | AMG407 | - | - | - | - | 2件: 56 56, 107 |
957 | AMG531 | - | - | - | - | 2件: 60 60, 63 |
958 | AMG592 | - | - | - | - | 2件: 46 46, 49 |
959 | AMG811 | - | - | - | - | 1件: 49 49 |
960 | Amgevita | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 |
961 | AMGEVITA (Adalimumab biosimilar ) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 |
962 | Amgevita 40 mg Injektionslösung im Fertigpen | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 |
963 | Amgevita 40 mg Injektionslösung in einer Fertigspritze | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 |
964 | Amgevita 40Mg Solution for Injection | - | - | - | - | 2件: 96 96, 97 |
965 | AMGEVITA® | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 |
966 | AMIAS | - | - | - | - | 1件: 67 67 |
967 | AMIFAMPRIDINA | - | - | - | - | 2件: 3 3, 11 |
968 | Amifampridina fosfato | - | - | - | - | 2件: 3 3, 11 |
969 | Amifampridine | 1件: Amifampridine Amifampridine | 1件: D10228
D10228
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 3件: 3 3, 11, 12 |
970 | Amifampridine Phosphate | 2件: Amifampridine Amifampridine, Phosphate ion | 1件: D10228
D10228
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 3件: 3 3, 11, 12 |
971 | Amifampridine Phosphate 10 MG Oral Tablet | 2件: Amifampridine Amifampridine, Phosphate ion | 1件: D10228
D10228
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 3 3 |
972 | Amifostine | 1件: Amifostine Amifostine | 1件: D00226
D00226
| - | - | 1件: 28 28 |
973 | Amifostine trihydrate | 1件: Amifostine Amifostine | 1件: D00226
D00226
| - | - | 1件: 28 28 |
974 | AMIKACIN | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 2件: 60 60, 299 |
975 | Amikacin nebulization | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
976 | AMIKACIN SULFATE | 2件: Amikacin Amikacin, Sulfate ion | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
977 | Amikacina | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
978 | Amikacina liposomal (Arikace?) | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
979 | Amikacine | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
980 | Amikacine nebulization | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
981 | Amikin, amiklin, amicacin, BB-K8, Biklin, Fabianol, Kaminax, Mikavir, Novamin, Pierami | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
982 | Amikin®, amiklin, amicacin, BB-K8, Biklin®, Fabianol®, Kaminax, Mikavir, Novamin®, Pierami | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
983 | AMILASA | - | - | - | - | 1件: 299 299 |
984 | Amiloride | 1件: Amiloride Amiloride | 2件: D00649
D00649
,
D07447
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬 | 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 4件: 13 13, 67, 225, 299 |
985 | Amiloride HCl | 1件: Amiloride Amiloride | 2件: D00649
D00649
,
D07447
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬 | 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 299 299 |
986 | Amiloride Hydrochloride | 1件: Amiloride Amiloride | 2件: D00649
D00649
,
D07447
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬 | 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 13 13 |
987 | AMILORIDE HYDROCHLORIDE, 2 H2O | 1件: Amiloride Amiloride | 2件: D00649
D00649
,
D07447
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬 | 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 13 13 |
988 | Amiloride Solution for Inhalation | 1件: Amiloride Amiloride | 2件: D00649
D00649
,
D07447
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬 | 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 299 299 |
989 | Amilostad | - | - | - | - | 1件: 13 13 |
990 | Amilostad HCT | - | - | - | - | 1件: 13 13 |
991 | Amilostad HCT tablets | - | - | - | - | 1件: 13 13 |
992 | Amino acids | 1件: Amino acids Amino acids | - | - | - | 3件: 70 70, 240, 298 |
993 | Aminocaproic acid | 1件: Aminocaproic acid Aminocaproic acid | 1件: D00160
D00160
| 1件: PLG PLG 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | 1件: 70 70 |
994 | Aminohippurate | 1件: Aminohippuric acid Aminohippuric acid | 2件: D01421
D01421
,
D06890
| - | - | 1件: 67 67 |
995 | Aminohippurate Sodium Inj 20% | 1件: Aminohippuric acid Aminohippuric acid | 2件: D01421
D01421
,
D06890
| - | - | 1件: 67 67 |
996 | Aminolevulinic acid | 1件: Aminolevulinic acid Aminolevulinic acid | 2件: D02908
D02908
,
D07567
| - | - | 4件: 34 34, 96, 254, 286 |
997 | Aminophylline | 1件: Aminophylline Aminophylline | 2件: D00227
D00227
,
D05429
| 18件: ADORA1 ADORA1, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 | 23件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 63 63 |
998 | Aminopterin | 1件: Aminopterin Aminopterin | - | - | - | 1件: 46 46 |
999 | AMINOSALICYLIC ACID | 1件: Aminosalicylic acid Aminosalicylic acid | 1件: D00162
D00162
| - | - | 2件: 96 96, 97 |
1000 | Amiodarone | 1件: Amiodarone Amiodarone | 2件: D00636
D00636
,
D02910
| 16件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 32件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 28 28, 127 |
1001 | Amiselimod | - | - | - | - | 1件: 97 97 |
1002 | Amitriptylin | 1件: Amitriptyline Amitriptyline | 2件: D00809
D00809
,
D07448
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 299 299 |
1003 | Amitriptylin-CT | 1件: Amitriptyline Amitriptyline | 2件: D00809
D00809
,
D07448
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 299 299 |
1004 | Amitriptylin-ct Tabletten | 1件: Amitriptyline Amitriptyline | 2件: D00809
D00809
,
D07448
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 299 299 |
1005 | Amitriptyline | 1件: Amitriptyline Amitriptyline | 2件: D00809
D00809
,
D07448
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 78 78, 97, 226, 299 |
1006 | Amitriptyline hydrochloride | 1件: Amitriptyline Amitriptyline | 2件: D00809
D00809
,
D07448
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 97 97 |
1007 | Amitriptyline, fluoxetine and tramadol alone (control group) | 3件: Amitriptyline Amitriptyline, Fluoxetine, Tramadol | 6件: D00326
D00326
,
D00809
,
D00823
,
D01355
,
D07448
,
D08623
| 3件: OPRM1 OPRM1, SLC6A2, SLC6A4 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 78 78 |
1008 | Amivita | - | - | - | - | 1件: 2 2 |
1009 | Amlodipine | 1件: Amlodipine Amlodipine | 3件: D00615
D00615
,
D02914
,
D07450
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 51 51, 67, 298 |
1010 | Amlodipine (drug) | 1件: Amlodipine Amlodipine | 3件: D00615
D00615
,
D02914
,
D07450
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 298 298 |
1011 | Amlodipine Gel | 1件: Amlodipine Amlodipine | 3件: D00615
D00615
,
D02914
,
D07450
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 51 51 |
1012 | Ammonia | 1件: Ammonia Ammonia | 1件: D02916
D02916
| - | - | 3件: 86 86, 88, 296 |
1013 | Ammonium (15N) chloride | 1件: Chloride ion Chloride ion | - | - | - | 1件: 251 251 |
1014 | Ammonium chloride | 2件: Ammonium chloride Ammonium chloride, Chloride ion | 1件: D01139
D01139
| - | - | 3件: 96 96, 107, 251 |
1015 | AMN107 | - | - | - | - | 2件: 34 34, 86 |
1016 | Amniotic Epithelial Cells | 1件: Amniotic Epithelial Cells Amniotic Epithelial Cells | - | - | - | 1件: 26 26 |
1017 | Amniotic Fluid Allograft | - | - | - | - | 1件: 70 70 |
1018 | Amorphous calcium carbonate | 2件: Calcium Calcium, Carbonate ion | - | - | - | 1件: 235 235 |
1019 | Amoxapine | 1件: Amoxapine Amoxapine | 1件: D00228
D00228
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 46 46 |
1020 | Amoxapine & dipyridamole | 2件: Amoxapine Amoxapine, Dipyridamole | 2件: D00228
D00228
,
D00302
| 4件: PDE4A PDE4A, PDE5A, SLC6A2, SLC6A4 💬 | 8件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 |
1021 | Amoxicilina | 1件: Amoxicillin Amoxicillin | 3件: D00229
D00229
,
D02925
,
D07452
| - | - | 1件: 46 46 |
1022 | Amoxicillin | 1件: Amoxicillin Amoxicillin | 3件: D00229
D00229
,
D02925
,
D07452
| - | - | 7件: 6 6, 46, 63, 96, 97, 222, 299 |
1023 | Amoxicillin and Clavulanic acid | 2件: Amoxicillin Amoxicillin, Clavulanic acid | 4件: D00229
D00229
,
D02925
,
D07452
,
D07711
| - | - | 1件: 299 299 |
1024 | Amoxicillin and doxycyclin | 2件: Amoxicillin Amoxicillin, Doxycycline | 8件: D00229
D00229
,
D00307
,
D02129
,
D02925
,
D03903
,
D03904
,
D07452
,
D07876
| - | - | 1件: 97 97 |
1025 | Amoxicillin hydrate | 1件: Amoxicillin Amoxicillin | 3件: D00229
D00229
,
D02925
,
D07452
| - | - | 1件: 63 63 |
1026 | Amoxicillin, metronidazole and doxycycline | 3件: Amoxicillin Amoxicillin, Doxycycline, Metronidazole | 11件: D00229
D00229
,
D00307
,
D00409
,
D02129
,
D02925
,
D03903
,
D03904
,
D05016
,
D05017
,
D07452
,
D07876
| - | - | 1件: 97 97 |
1027 | Amoxycillin | 1件: Amoxicillin Amoxicillin | 3件: D00229
D00229
,
D02925
,
D07452
| - | - | 1件: 63 63 |
1028 | AMP | - | - | - | - | 1件: 46 46 |
1029 | AMP-110 | - | - | - | - | 1件: 46 46 |
1030 | Ampalex | - | - | - | - | 1件: 206 206 |
1031 | AMPC | 1件: Cyclic adenosine monophosphate Cyclic adenosine monophosphate | - | - | - | 1件: 84 84 |
1032 | Amphotericin | - | - | - | - | 1件: 299 299 |
1033 | Amphotericin B | 1件: Amphotericin B Amphotericin B | 1件: D00203
D00203
| - | - | 1件: 299 299 |
1034 | AMPHOTERICINE B, LIPOSOME | - | - | - | - | 1件: 60 60 |
1035 | Ampreloxetine | 1件: Ampreloxetine Ampreloxetine | 1件: D11688
D11688
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 17 |
1036 | Ampreloxetine chydrochloride | 1件: Ampreloxetine Ampreloxetine | 1件: D11688
D11688
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 17 |
1037 | Ampreloxetine hydrochloride | 1件: Ampreloxetine Ampreloxetine | 1件: D11688
D11688
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 17 |
1038 | Amprenavir | 1件: Amprenavir Amprenavir | 1件: D00894
D00894
| - | - | 1件: 265 265 |
1039 | Ampyra | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 6 6, 13 |
1040 | Ampyra first, | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 6 6 |
1041 | AMSC | - | - | - | - | 1件: 2 2 |
1042 | AMT | - | - | - | - | 4件: 8 8, 46, 97, 321 |
1043 | AMT-101 | - | - | - | - | 2件: 46 46, 97 |
1044 | AMT-101 (oral) | - | - | - | - | 1件: 97 97 |
1045 | AMT-130 | - | - | - | - | 1件: 8 8 |
1046 | AMX0035 | - | - | - | - | 1件: 2 2 |
1047 | Amyl Nitrite | 2件: Amyl Nitrite Amyl Nitrite, Nitrite | 1件: D00517
D00517
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 |
1048 | Amyl nitrite inhalation | 2件: Amyl Nitrite Amyl Nitrite, Nitrite | 1件: D00517
D00517
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 |
1049 | AMYLASE | - | - | - | - | 1件: 299 299 |
1050 | Amyvid | 1件: Florbetapir (18F) Florbetapir (18F) | - | - | - | 2件: 13 13, 127 |
1051 | Amyvid radiopharmaceutical | 1件: Florbetapir (18F) Florbetapir (18F) | - | - | - | 1件: 13 13 |
1052 | AMZ002 | - | - | - | - | 1件: 145 145 |
1053 | AN100226 | - | - | - | - | 2件: 13 13, 96 |
1054 | AN100226, BG00002 | - | - | - | - | 1件: 13 13 |
1055 | ANA001XHCl (Syntagon) or VEXA-04 (Patheon) | - | - | - | - | 1件: 156 156 |
1056 | ANACETRAPIB | 1件: Anacetrapib Anacetrapib | 1件: D08855
D08855
| 1件: CETP CETP 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
1057 | Anaerobically Cultivated Human Intestinal Microbiota | - | - | - | - | 1件: 51 51 |
1058 | Anaerobically Cultivated medium | - | - | - | - | 1件: 51 51 |
1059 | Anakinra | 1件: Anakinra Anakinra | 1件: D02934
D02934
| 2件: IL1R1 IL1R1, IL1R2 💬 | 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 17件: 2 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 |
1060 | Anakinra (Kineret®) | 1件: Anakinra Anakinra | 1件: D02934
D02934
| 2件: IL1R1 IL1R1, IL1R2 💬 | 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 1件: 46 46 |
1061 | Anakinra (r-metHuIL-1ra) | 1件: Anakinra Anakinra | 1件: D02934
D02934
| 2件: IL1R1 IL1R1, IL1R2 💬 | 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 1件: 46 46 |
1062 | Anakinra / kineret | 1件: Anakinra Anakinra | 1件: D02934
D02934
| 2件: IL1R1 IL1R1, IL1R2 💬 | 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 1件: 107 107 |
1063 | Anakinra and PEG sTNF-R1 | 2件: Anakinra Anakinra, Pegsunercept | 2件: D02934
D02934
,
D05393
| 3件: IL1R1 IL1R1, IL1R2, TNF 💬 | 71件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
1064 | Analgesics | - | - | - | - | 1件: 298 298 |
1065 | Analysis of gamma globulin | - | - | - | - | 1件: 84 84 |
1066 | ANASTROZOLE | 1件: Anastrozole Anastrozole | 1件: D00960
D00960
| 1件: CYP19A1 CYP19A1 💬 | 3件: Metabolic pathways Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬 | 3件: 78 78, 86, 193 |
1067 | Anatomical Landmark-guided Suprascapular Nerve Block | - | - | - | - | 1件: 149 149 |
1068 | ANAVEX2-73 | - | - | - | - | 2件: 6 6, 156 |
1069 | ANAVEX2-73 (blarcamesine) | 1件: Blarcamesine Blarcamesine | 1件: D11383
D11383
| 6件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, SIGMAR1 💬 | 14件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 156 156 |
1070 | ANAVEX2-73 oral liquid | - | - | - | - | 1件: 156 156 |
1071 | ANB019 | - | - | - | - | 1件: 37 37 |
1072 | AND (Andrographolide) | 1件: Andrographolide Andrographolide | - | - | - | 1件: 97 97 |
1073 | Andecaliximab | - | - | - | - | 4件: 46 46, 96, 97, 299 |
1074 | AndoSan | - | - | - | - | 2件: 96 96, 97 |
1075 | AndroGel 1 % Topical Gel | - | - | - | - | 1件: 13 13 |
1076 | Androgel 10 grams of gel containing 100 mg of testosterone | 1件: Testosterone Testosterone | 6件: D00075
D00075
,
D00957
,
D00958
,
D00959
,
D06085
,
D06087
| 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 13 13 |
1077 | Androgens | - | - | - | - | 1件: 60 60 |
1078 | ANDROGRAPHIS PANICULATA | - | - | - | - | 1件: 97 97 |
1079 | ANDROGRAPHIS PANICULATA (ethanol extract) | 1件: Ethanol Ethanol | 4件: D00068
D00068
,
D02798
,
D04855
,
D06542
| - | - | 1件: 97 97 |
1080 | Andrographolide | 1件: Andrographolide Andrographolide | - | - | - | 1件: 97 97 |
1081 | Andrographolides | - | - | - | - | 1件: 13 13 |
1082 | Anesthetic Topical Adhesive Synera | - | - | - | - | 1件: 13 13 |
1083 | Anfibatide | 1件: Anfibatide Anfibatide | - | - | - | 1件: 64 64 |
1084 | Angiotensin | 1件: Angiotensin II Angiotensin II | 2件: D00150
D00150
,
D02014
| 2件: AGTR1 AGTR1, AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 7件: 17 17, 19, 46, 66, 86, 222, 224 |
1085 | Angiotensin blockade | 1件: Angiotensin II Angiotensin II | 2件: D00150
D00150
,
D02014
| 2件: AGTR1 AGTR1, AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 66 66 |
1086 | Angiotensin II | 1件: Angiotensin II Angiotensin II | 2件: D00150
D00150
,
D02014
| 2件: AGTR1 AGTR1, AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 66 66, 222 |
1087 | Angiotensin receptor blockers | 1件: Angiotensin II Angiotensin II | 2件: D00150
D00150
,
D02014
| 2件: AGTR1 AGTR1, AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 46 46 |
1088 | Angiotensin-(1-7) | 1件: Angiotensin II Angiotensin II | 2件: D00150
D00150
,
D02014
| 2件: AGTR1 AGTR1, AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 17 17 |
1089 | Angiotensin-converting enzyme (ACE) inhibitor | 1件: Angiotensin II Angiotensin II | 2件: D00150
D00150
,
D02014
| 2件: AGTR1 AGTR1, AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 224 224 |
1090 | Angiotensin-converting enzyme inhibitor(ACEI) | 1件: Angiotensin II Angiotensin II | 2件: D00150
D00150
,
D02014
| 2件: AGTR1 AGTR1, AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 224 224 |
1091 | Anhydrous Amiloride Hydrochloride | 1件: Amiloride Amiloride | 2件: D00649
D00649
,
D07447
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬 | 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 225 225 |
1092 | ANHYDROUS CARBIDOPA | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1093 | ANIFROLUMAB | 1件: Anifrolumab Anifrolumab | 1件: D11082
D11082
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 2件: 46 46, 49 |
1094 | Anifrolumab (MEDI-546) | 1件: Anifrolumab Anifrolumab | 1件: D11082
D11082
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 46 46 |
1095 | Anifrolumab 1000 mg | 1件: Anifrolumab Anifrolumab | 1件: D11082
D11082
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 49 49 |
1096 | Anifrolumab 300 mg | 1件: Anifrolumab Anifrolumab | 1件: D11082
D11082
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 49 49 |
1097 | Anit human granulocyt-macrophage colony-stimulating factor (GM-CSF)monoclonal | - | - | - | - | 1件: 46 46 |
1098 | ANK-700 | - | - | - | - | 1件: 13 13 |
1099 | Anle138b | 1件: anle138b anle138b | - | - | - | 1件: 6 6 |
1100 | Anrukinzumab | 1件: Anrukinzumab Anrukinzumab | 1件: D08857
D08857
| 1件: IL13 IL13 💬 | 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | 1件: 97 97 |
1101 | Anti BAFF (B cell activating factor) | - | - | - | - | 1件: 49 49 |
1102 | Anti Beta7 | - | - | - | - | 1件: 97 97 |
1103 | Anti CD3 monoclonal antibody | - | - | - | - | 1件: 97 97 |
1104 | Anti human granulocyte-macrophage colo | - | - | - | - | 1件: 46 46 |
1105 | Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) MONOCLONAL | - | - | - | - | 1件: 46 46 |
1106 | Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal antibody | - | - | - | - | 1件: 46 46 |
1107 | Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF)monoclonal | - | - | - | - | 1件: 46 46 |
1108 | Anti IL 6 mAb | - | - | - | - | 1件: 46 46 |
1109 | Anti IL-1beta antibody | - | - | - | - | 1件: 46 46 |
1110 | Anti IL-1beta antibody, subclass IgG4 | - | - | - | - | 1件: 46 46 |
1111 | Anti IL-1ß antibody | - | - | - | - | 1件: 46 46 |
1112 | Anti IL-1ß antibody, subclass IgG4 | - | - | - | - | 1件: 46 46 |
1113 | Anti LP40 antibody, subclass IgG4 | - | - | - | - | 1件: 49 49 |
1114 | Anti LP40 antibody, subclass IgG4 LA294 | - | - | - | - | 2件: 13 13, 46 |
1115 | Anti LP40 anticuerpo, subclase IgG4 | - | - | - | - | 1件: 49 49 |
1116 | Anti Lymphotoxin Alpha | - | - | - | - | 1件: 46 46 |
1117 | Anti TNF | - | - | - | - | 1件: 96 96 |
1118 | Anti TNF + Meth | - | - | - | - | 1件: 46 46 |
1119 | Anti TNF Alfa. | - | - | - | - | 1件: 96 96 |
1120 | Anti TNF alpha agent | - | - | - | - | 1件: 271 271 |
1121 | Anti TNF alpha therapy | - | - | - | - | 1件: 271 271 |
1122 | Anti TNF humanized antibody Fab fragment-PEG conjugate | - | - | - | - | 1件: 96 96 |
1123 | Anti TNF therapy including infliximab | 1件: Infliximab Infliximab | 1件: D02598
D02598
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 |
1124 | Anti-(complement C5a) IgG4 chimeric monoclonal antibody | - | - | - | - | 1件: 269 269 |
1125 | Anti-(human tumor necrosis factor) immunoglobulin G (human-mouse monoclonal cA2 heavy chain) | - | - | - | - | 1件: 271 271 |
1126 | Anti-BAFFR antibody | - | - | - | - | 1件: 95 95 |
1127 | Anti-Beta Interferon (PF-06823859) | - | - | - | - | 1件: 50 50 |
1128 | Anti-blood dendritic cell antigen 2 | - | - | - | - | 1件: 49 49 |
1129 | Anti-C5 antibody | - | - | - | - | 4件: 11 11, 14, 62, 109 |
1130 | Anti-C5aR | - | - | - | - | 1件: 46 46 |
1131 | Anti-CD19-CAR-T cells | - | - | - | - | 1件: 49 49 |
1132 | Anti-CD20 B cell depletion with Truxima | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 49 49 |
1133 | Anti-CD20 small modular immunopharmaceutical, WYE-400087 | - | - | - | - | 1件: 46 46 |
1134 | Anti-CD25 Humanized Monoclonal Antibody | - | - | - | - | 1件: 13 13 |
1135 | Anti-CD28dAb | - | - | - | - | 3件: 49 49, 53, 160 |
1136 | Anti-CD3 | 1件: Muromonab Muromonab | 1件: D05092
D05092
| 3件: CD3D CD3D, CD3E, CD3G 💬 | 11件: Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 2件: 96 96, 97 |
1137 | Anti-CD3 Monoclonal antibody | 1件: Muromonab Muromonab | 1件: D05092
D05092
| 3件: CD3D CD3D, CD3E, CD3G 💬 | 11件: Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 2件: 96 96, 97 |
1138 | Anti-CD40L | 1件: Toralizumab Toralizumab | 1件: D06193
D06193
| 1件: CD40LG CD40LG 💬 | 14件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis 💬 | 1件: 63 63 |
1139 | Anti-CD40LdAb | - | - | - | - | 1件: 63 63 |
1140 | Anti-CD45 | - | - | - | - | 3件: 60 60, 65, 285 |
1141 | Anti-CD52 monoclonal antibody | - | - | - | - | 1件: 13 13 |
1142 | Anti-CT51 antigen mAb | - | - | - | - | 1件: 51 51 |
1143 | Anti-D | - | - | - | - | 1件: 63 63 |
1144 | Anti-GM-CSF receptor alpha | - | - | - | - | 1件: 46 46 |
1145 | Anti-human immunoglobulin, equine | - | - | - | - | 1件: 60 60 |
1146 | Anti-Human Interleukin-23 Monoclonal Antibody | - | - | - | - | 1件: 271 271 |
1147 | Anti-human T-lymphocyte immunoglobulin from horse | - | - | - | - | 1件: 60 60 |
1148 | ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN FROM RABBITS | - | - | - | - | 1件: 51 51 |
1149 | Anti-hypertensive medications | - | - | - | - | 1件: 67 67 |
1150 | Anti-IL-12 | - | - | - | - | 2件: 13 13, 96 |
1151 | Anti-IL-20 | 1件: Fletikumab Fletikumab | 1件: D11756
D11756
| 1件: IL20 IL20 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
1152 | Anti-IL-20 (109-0012) | 1件: Fletikumab Fletikumab | 1件: D11756
D11756
| 1件: IL20 IL20 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
1153 | Anti-IL-23 monoclonal antibody | - | - | - | - | 1件: 96 96 |
1154 | Anti-IL-36R monoclonal antibody | - | - | - | - | 1件: 37 37 |
1155 | Anti-IL-6 mAb | - | - | - | - | 2件: 46 46, 96 |
1156 | Anti-inflammatory drugs | - | - | - | - | 1件: 46 46 |
1157 | Anti-integrin alphaV mAb | - | - | - | - | 1件: 51 51 |
1158 | Anti-Interferon-gamma monoclonal antibody | - | - | - | - | 1件: 96 96 |
1159 | Anti-interleukin-1B monoclonal antibody | - | - | - | - | 1件: 106 106 |
1160 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma | - | - | - | - | 2件: 96 96, 97 |
1161 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human | - | - | - | - | 2件: 96 96, 97 |
1162 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody | - | - | - | - | 2件: 96 96, 97 |
1163 | Anti-Interleukin-6 Monoclonal | - | - | - | - | 1件: 46 46 |
1164 | Anti-Interleukin-6 Monoclonal Antibody | - | - | - | - | 2件: 46 46, 96 |
1165 | Anti-IP-10 Antibody | - | - | - | - | 1件: 97 97 |
1166 | Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody | - | - | - | - | 1件: 49 49 |
1167 | Anti-MAdCAM antibody | - | - | - | - | 2件: 96 96, 97 |
1168 | Anti-myostati | - | - | - | - | 1件: 113 113 |
1169 | Anti-Myostatin Adnectin | - | - | - | - | 1件: 113 113 |
1170 | Anti-pandemic H1N1 influenza vaccine | - | - | - | - | 6件: 46 46, 49, 50, 51, 53, 107 |
1171 | Anti-Parkinson medication | - | - | - | - | 5件: 5 5, 6, 7, 8, 17 |
1172 | Anti-Parkinsonian Drugs | - | - | - | - | 1件: 6 6 |
1173 | Anti-pseudomonas IgY gargle | - | - | - | - | 1件: 299 299 |
1174 | Anti-reflux pharmacotherapy | - | - | - | - | 1件: 299 299 |
1175 | ANTI-SCLEROSTIN MONOCLONAL ANTIBODY | - | - | - | - | 1件: 274 274 |
1176 | Anti-Thymocyte Globulin | - | - | - | - | 18件: 11 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 |
1177 | Anti-thymocyte globulin (ATG) | - | - | - | - | 1件: 164 164 |
1178 | Anti-thymocyte globulin (horse) | - | - | - | - | 1件: 60 60 |
1179 | Anti-Thymocyte Globulin (Rabbit) | 1件: Rabbit Rabbit | - | - | - | 4件: 60 60, 65, 96, 285 |
1180 | Anti-Thymocyte Globulin, Rabbit | 2件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | - | - | - | 1件: 51 51 |
1181 | Anti-TL1A | - | - | - | - | 1件: 97 97 |
1182 | Anti-TNF | - | - | - | - | 4件: 46 46, 96, 107, 271 |
1183 | Anti-TNF agents | - | - | - | - | 1件: 271 271 |
1184 | Anti-TNF biologics | - | - | - | - | 2件: 46 46, 271 |
1185 | Anti-TNF Biologics Therapy | - | - | - | - | 1件: 46 46 |
1186 | Anti-TNF discontinuation: Physiological saline solution | - | - | - | - | 2件: 96 96, 97 |
1187 | Anti-TNF Drug | - | - | - | - | 2件: 96 96, 97 |
1188 | Anti-TNF humanized antibody Fab fragment - PEG conjugate | - | - | - | - | 1件: 46 46 |
1189 | Anti-TNF humanized antibody Fab' fragment - PEG conjugate | - | - | - | - | 1件: 46 46 |
1190 | Anti-TNF suspended perioperatively | - | - | - | - | 1件: 46 46 |
1191 | Anti-TNF therapy | - | - | - | - | 3件: 46 46, 96, 97 |
1192 | Anti-TNF therapy (etanercept or adalimumab) | 2件: Adalimumab Adalimumab, Etanercept | 2件: D00742
D00742
,
D02597
| 2件: LTA LTA, TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 271 |
1193 | Anti-TNF-alpha | - | - | - | - | 1件: 46 46 |
1194 | Anti-TNF: Infliximab (Infusion) | 1件: Infliximab Infliximab | 1件: D02598
D02598
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 |
1195 | Anti-TNF:Adalimumab (Subcutaneus) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 |
1196 | Anti-TNFa continued perioperatively | - | - | - | - | 1件: 46 46 |
1197 | Anti-Tumor Necrosing Factor (TNF) Therapy | - | - | - | - | 1件: 46 46 |
1198 | Anti-Tumor Necrosis Factor | - | - | - | - | 1件: 271 271 |
1199 | Anti-Tumor Necrosis Factor Alpha Drug (Product) | - | - | - | - | 1件: 46 46 |
1200 | Anti-tumor necrosis factor alpha monoclonal antibody | - | - | - | - | 1件: 107 107 |
1201 | Anti-von Willebrand Factor Nanobody | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 64 64 |
1202 | Anti-von Willebrand Factor Nanobody, Caplacizumab | 2件: Caplacizumab Caplacizumab, Von Willebrand factor human | 1件: D11160
D11160
| 1件: VWF VWF 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 1件: 64 64 |
1203 | Anti-von Willebrand Factor Nanobody, INN = Caplacizumab | 2件: Caplacizumab Caplacizumab, Von Willebrand factor human | 1件: D11160
D11160
| 1件: VWF VWF 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 1件: 64 64 |
1204 | Antiarrhythmic drugs | - | - | - | - | 1件: 58 58 |
1205 | Antibiotic | - | - | - | - | 1件: 299 299 |
1206 | Antibiotic cocktail | - | - | - | - | 1件: 97 97 |
1207 | Antibiotic Regimen | - | - | - | - | 1件: 84 84 |
1208 | Antibiotics | - | - | - | - | 1件: 96 96 |
1209 | Anticholinergic medication | - | - | - | - | 1件: 13 13 |
1210 | Anticorpo monoclonale anti GM-CSF umano | - | - | - | - | 1件: 46 46 |
1211 | Anticorpo monoclonale anti IL-23 | - | - | - | - | 1件: 96 96 |
1212 | Anticorpo monoclonale anti-IL-23 | - | - | - | - | 1件: 96 96 |
1213 | Anticorpo monoclonale umano anti-Interleuchina-23 Immunoglobulina G2 (IgG2) | - | - | - | - | 1件: 96 96 |
1214 | Anticuerpo monoclonal anti-humano recombinante humanizado, receptor de IL-6R. | - | - | - | - | 1件: 46 46 |
1215 | Anticuerpo monoclonal anti-LINGO-1 humano | - | - | - | - | 1件: 13 13 |
1216 | Antiepileptic drug (1 to 3 only) | - | - | - | - | 1件: 158 158 |
1217 | Antigen-specific T cells CART/CTL and DCvac | - | - | - | - | 1件: 34 34 |
1218 | Antihemophilic Factor (Recombinant) | - | - | - | - | 1件: 288 288 |
1219 | Antihistamine | - | - | - | - | 2件: 13 13, 46 |
1220 | Antihistamine (cetirizine or equivalent) | 1件: Cetirizine Cetirizine | 2件: D00664
D00664
,
D07662
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 35 35 |
1221 | Antihuman granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal | - | - | - | - | 1件: 46 46 |
1222 | Antihypertensive drugs | - | - | - | - | 1件: 67 67 |
1223 | Antilymphocyte serum | - | - | - | - | 1件: 60 60 |
1224 | Antimicrobial therapy: Co-trimoxazole or Doxycycline | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 85 85 |
1225 | Antimycotic | - | - | - | - | 1件: 13 13 |
1226 | Antioxidant Cocktail | - | - | - | - | 1件: 299 299 |
1227 | Antioxidant plus Pregabalin | 1件: Pregabalin Pregabalin | 1件: D02716
D02716
| 4件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 | 7件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | 1件: 298 298 |
1228 | Antioxidants | - | - | - | - | 3件: 90 90, 298, 310 |
1229 | Antiparkinsonian Agent(s) | - | - | - | - | 1件: 6 6 |
1230 | Antiplatelets | - | - | - | - | 1件: 124 124 |
1231 | Antipyretic | - | - | - | - | 1件: 257 257 |
1232 | Antiretroviral/Anti HIV | - | - | - | - | 1件: 265 265 |
1233 | Antisense oligonucleotide | - | - | - | - | 1件: 5 5 |
1234 | Antistaminici H1 - H2 | - | - | - | - | 1件: 299 299 |
1235 | Antithymocyte | - | - | - | - | 1件: 13 13 |
1236 | Antithymocyte Globulin | - | - | - | - | 3件: 60 60, 65, 284 |
1237 | Antithymocyte Globulin (ATG) | - | - | - | - | 1件: 60 60 |
1238 | Antithymocyte globulin (Rabbit) | 1件: Rabbit Rabbit | - | - | - | 1件: 60 60 |
1239 | ANTITHYMOCYTE IMMUNOGLOBULIN | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | 2件: 13 13, 96 |
1240 | Antithymocyte immunoglobulin (rabbit) | 2件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | - | - | - | 2件: 13 13, 96 |
1241 | Antituberculous therapy along with steroids | - | - | - | - | 1件: 84 84 |
1242 | Antiviral therapy | - | - | - | - | 2件: 28 28, 60 |
1243 | Antivirale ad uso diretto | - | - | - | - | 1件: 107 107 |
1244 | ANTOX | - | - | - | - | 1件: 298 298 |
1245 | ANTOX (vers) 1.2 | - | - | - | - | 1件: 298 298 |
1246 | ANTOX (vers.)1.2 | - | - | - | - | 1件: 298 298 |
1247 | Antox version 1.2 | - | - | - | - | 1件: 298 298 |
1248 | ANX005 | - | - | - | - | 3件: 2 2, 8, 61 |
1249 | Anxiety/depression and work and activities | - | - | - | - | 1件: 13 13 |
1250 | Any other approved Antiepileptic Drug | - | - | - | - | 1件: 144 144 |
1251 | AOC 1001 | - | - | - | - | 1件: 113 113 |
1252 | AODG (Apigenin-7-O-glucuronide) | 1件: Apigenin Apigenin | - | - | - | 1件: 97 97 |
1253 | AP | - | - | - | - | 4件: 2 2, 6, 13, 299 |
1254 | AP-101 | - | - | - | - | 1件: 2 2 |
1255 | AP-CD/LD | - | - | - | - | 1件: 6 6 |
1256 | AP-PA02 | - | - | - | - | 1件: 299 299 |
1257 | AP01 | - | - | - | - | 1件: 85 85 |
1258 | AP09004 | - | - | - | - | 1件: 6 6 |
1259 | AP1189 | - | - | - | - | 2件: 46 46, 222 |
1260 | AP1903 | - | - | - | - | 3件: 60 60, 285, 326 |
1261 | AP1903 A594 | - | - | - | - | 3件: 60 60, 285, 326 |
1262 | Apabetalone | 1件: Apabetalone Apabetalone | 1件: D11131
D11131
| 4件: BRD2 BRD2, BRD3, BRD4, BRDT 💬 | - | 1件: 86 86 |
1263 | Apadamtase alfa | 1件: Apadamtase alfa Apadamtase alfa | - | - | - | 1件: 64 64 |
1264 | Apademtase alfa | - | - | - | - | 1件: 64 64 |
1265 | APCC, aPCC + TXA | - | - | - | - | 1件: 288 288 |
1266 | APD334 | - | - | - | - | 5件: 93 93, 96, 97, 98, 269 |
1267 | APD334 L-arginine | 1件: Arginine Arginine | 1件: D02982
D02982
| - | - | 1件: 97 97 |
1268 | APD371 | - | - | - | - | 1件: 96 96 |
1269 | APD421 | - | - | - | - | 1件: 107 107 |
1270 | APD811 | - | - | - | - | 1件: 86 86 |
1271 | Apelin | - | - | - | - | 1件: 86 86 |
1272 | Apheresis | - | - | - | - | 1件: 60 60 |
1273 | Apheresis catheter placement | - | - | - | - | 1件: 96 96 |
1274 | API | - | - | - | - | 2件: 231 231, 299 |
1275 | API-AAT | - | - | - | - | 1件: 231 231 |
1276 | API-AAT, AD00370, ARC-AAT, API drug Substance | - | - | - | - | 1件: 231 231 |
1277 | Apigenin | 1件: Apigenin Apigenin | - | - | - | 1件: 97 97 |
1278 | Apitegromab | 1件: Apitegromab Apitegromab | 1件: D11797
D11797
| 1件: MSTN MSTN 💬 | 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 1件: 3 3 |
1279 | Apitox - pure honeybee toxin | - | - | - | - | 1件: 13 13 |
1280 | Apixaban | 1件: Apixaban Apixaban | 1件: D03213
D03213
| 1件: F10 F10 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 3件: 96 96, 97, 222 |
1281 | Apixaban 2.5 milligram | 1件: Apixaban Apixaban | 1件: D03213
D03213
| 1件: F10 F10 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 2件: 96 96, 97 |
1282 | Apixaban 5 MG | 1件: Apixaban Apixaban | 1件: D03213
D03213
| 1件: F10 F10 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 222 222 |
1283 | APL-130277 | - | - | - | - | 1件: 6 6 |
1284 | APL-2 | - | - | - | - | 5件: 2 2, 61, 62, 66, 222 |
1285 | APLA12 | - | - | - | - | 1件: 46 46 |
1286 | Aplindore | 1件: Aplindore Aplindore | - | - | - | 1件: 6 6 |
1287 | Aplindore MR tablets | 1件: Aplindore Aplindore | - | - | - | 1件: 6 6 |
1288 | APO-go | - | - | - | - | 1件: 6 6 |
1289 | APO-go® | - | - | - | - | 1件: 6 6 |
1290 | APO-P001 | - | - | - | - | 1件: 2 2 |
1291 | APOKINON | - | - | - | - | 1件: 6 6 |
1292 | APOKYN | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1293 | Apomor | - | - | - | - | 1件: 6 6 |
1294 | Apomorfina | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1295 | APOMORFINA CLORIDRATO | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1296 | Apomorp | - | - | - | - | 1件: 6 6 |
1297 | Apomorphine | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 5 5, 6, 7 |
1298 | Apomorphine 0.25% (2.5mg/ml) | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1299 | Apomorphine HCl injection | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1300 | APOMORPHINE HYDROCHLORIDE | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1301 | Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1302 | Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1303 | Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1304 | Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1305 | APOMORPHINE HYDROCHLORIDE HEMIHYDRATE | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1306 | Apomorphine Hydrocloride | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1307 | Apomorphine Hydrocloride Hemihydrate | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1308 | Apomorphine infusion | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1309 | Apomorphine Injectable Solution | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1310 | Apomorphine Nasal Powder | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1311 | APORON | - | - | - | - | 1件: 6 6 |
1312 | ApoTamox 10mg | - | - | - | - | 1件: 111 111 |
1313 | Apple | 1件: Apple Apple | - | - | - | 1件: 70 70 |
1314 | Apple Watch and App | 1件: Apple Apple | - | - | - | 1件: 70 70 |
1315 | Application of Adalimumab | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
1316 | Apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side | 1件: Sinecatechins Sinecatechins | 1件: D08997
D08997
| - | - | 1件: 160 160 |
1317 | Apraclonidine | 1件: Apraclonidine Apraclonidine | 2件: D01008
D01008
,
D07461
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 11 11 |
1318 | Apraclonidine Hcl 0.5% Oph Soln | 1件: Apraclonidine Apraclonidine | 2件: D01008
D01008
,
D07461
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 11 11 |
1319 | Apratastat | 1件: Apratastat Apratastat | 1件: D08859
D08859
| 2件: ADAM17 ADAM17, MMP13 💬 | 7件: Alzheimer disease Alzheimer disease, Coronavirus disease - COVID-19, Epithelial cell signaling in Helicobacter pylori infection, IL-17 signaling pathway, Notch signaling pathway, Parathyroid hormone synthesis, secretion and action, Relaxin signaling pathway 💬 | 1件: 46 46 |
1320 | Apremilast | 1件: Apremilast Apremilast | 1件: D08860
D08860
| 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 7件: 46 46, 50, 56, 97, 107, 162, 271 |
1321 | Apremilast (CC-10004) | 1件: Apremilast Apremilast | 1件: D08860
D08860
| 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 56 56 |
1322 | Apremilast 10 mg | 1件: Apremilast Apremilast | 1件: D08860
D08860
| 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 2件: 56 56, 107 |
1323 | Apremilast 20 mg | 1件: Apremilast Apremilast | 1件: D08860
D08860
| 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 3件: 46 46, 56, 107 |
1324 | Apremilast 30 mg | 1件: Apremilast Apremilast | 1件: D08860
D08860
| 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 3件: 46 46, 56, 107 |
1325 | Apremilast 30mg | 1件: Apremilast Apremilast | 1件: D08860
D08860
| 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 50 50 |
1326 | Apremilast tablet 20 mg | 1件: Apremilast Apremilast | 1件: D08860
D08860
| 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 271 271 |
1327 | Apremilast tablet 30 mg BID | 1件: Apremilast Apremilast | 1件: D08860
D08860
| 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 271 271 |
1328 | APRINOX | - | - | - | - | 1件: 67 67 |
1329 | Apriso 0.375G ER CAP | - | - | - | - | 1件: 97 97 |
1330 | APRISO 375 mg extended-release capsules | 1件: Manganese citrate Manganese citrate | - | - | - | 1件: 97 97 |
1331 | AProArt | - | - | - | - | 1件: 65 65 |
1332 | Aprotinin | 1件: Aprotinin Aprotinin | 1件: D02971
D02971
| - | - | 1件: 28 28 |
1333 | Aprovel | 1件: Irbesartan Irbesartan | 1件: D00523
D00523
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 167 167 |
1334 | Aprovel (150 mg) | 1件: Irbesartan Irbesartan | 1件: D00523
D00523
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 222 222 |
1335 | Aprovel 150 mg Tablets | 1件: Irbesartan Irbesartan | 1件: D00523
D00523
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 222 222 |
1336 | APT-1011 | - | - | - | - | 1件: 98 98 |
1337 | APT-1011 - 3 mg | - | - | - | - | 1件: 98 98 |
1338 | APVO210 | - | - | - | - | 1件: 97 97 |
1339 | AquADEK | - | - | - | - | 1件: 299 299 |
1340 | AquADEKs-2 | - | - | - | - | 1件: 299 299 |
1341 | Aquamin | - | - | - | - | 1件: 97 97 |
1342 | Aquamin® | - | - | - | - | 1件: 97 97 |
1343 | AQW051 | - | - | - | - | 1件: 6 6 |
1344 | AQX-1125 | 1件: AQX-1125 AQX-1125 | - | - | - | 1件: 226 226 |
1345 | AQX-1125 100 mg | 1件: AQX-1125 AQX-1125 | - | - | - | 1件: 226 226 |
1346 | AQX-1125 200 mg | 1件: AQX-1125 AQX-1125 | - | - | - | 1件: 226 226 |
1347 | AR-42 | 1件: AR-42 AR-42 | - | - | - | 1件: 34 34 |
1348 | AR392830 | - | - | - | - | 1件: 86 86 |
1349 | AR401959 L-arginine | 1件: Arginine Arginine | 1件: D02982
D02982
| - | - | 3件: 96 96, 97, 98 |
1350 | ARA 290 | - | - | - | - | 1件: 84 84 |
1351 | ARA290 | - | - | - | - | 1件: 46 46 |
1352 | Aramchol | 1件: Aramchol Aramchol | - | - | - | 1件: 265 265 |
1353 | ARAVA | 1件: Leflunomide Leflunomide | 1件: D00749
D00749
| 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 3件: 46 46, 53, 162 |
1354 | Arava 20 mg filmdrasjerte tabletter | - | - | - | - | 1件: 46 46 |
1355 | Arava 20 mg Tablets (Aventis Pharmaceutical, Inc.) | 1件: Leflunomide Leflunomide | 1件: D00749
D00749
| 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 46 46 |
1356 | ARAVA® | 1件: Leflunomide Leflunomide | 1件: D00749
D00749
| 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 46 46 |
1357 | ARB | - | - | - | - | 1件: 66 66 |
1358 | Arbaclofen | 1件: Arbaclofen Arbaclofen | 1件: D09791
D09791
| 2件: GABBR1 GABBR1, GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 2件: 13 13, 206 |
1359 | Arbaclofen ER Tablets | 1件: Arbaclofen Arbaclofen | 1件: D09791
D09791
| 2件: GABBR1 GABBR1, GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 |
1360 | Arbaclofen Extended Release Tablets | 1件: Arbaclofen Arbaclofen | 1件: D09791
D09791
| 2件: GABBR1 GABBR1, GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 |
1361 | Arbaclofen Placarbil | 2件: Arbaclofen Arbaclofen, Arbaclofen Placarbil | 2件: D08861
D08861
,
D09791
| 2件: GABBR1 GABBR1, GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 |
1362 | Arbaclofen placarbil 15 mg BID | 2件: Arbaclofen Arbaclofen, Arbaclofen Placarbil | 2件: D08861
D08861
,
D09791
| 2件: GABBR1 GABBR1, GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 |
1363 | Arbaclofen placarbil 30 mg BID | 2件: Arbaclofen Arbaclofen, Arbaclofen Placarbil | 2件: D08861
D08861
,
D09791
| 2件: GABBR1 GABBR1, GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 |
1364 | Arbaclofen placarbil 45 mg BID | 2件: Arbaclofen Arbaclofen, Arbaclofen Placarbil | 2件: D08861
D08861
,
D09791
| 2件: GABBR1 GABBR1, GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 |
1365 | ARC 1779 | - | - | - | - | 2件: 64 64, 288 |
1366 | ARC-AAT | - | - | - | - | 1件: 231 231 |
1367 | ARC-AAT Injection | - | - | - | - | 1件: 231 231 |
1368 | ARC1779 | - | - | - | - | 2件: 64 64, 288 |
1369 | ARC1779 Injection | - | - | - | - | 2件: 64 64, 288 |
1370 | ARC1905 | - | - | - | - | 1件: 301 301 |
1371 | ARC1905 20 MG/ML | - | - | - | - | 1件: 301 301 |
1372 | ARCOXIA | - | - | - | - | 2件: 46 46, 271 |
1373 | ARCOXIA 90 mg comprimidos recubiertos con película | - | - | - | - | 1件: 271 271 |
1374 | ARCT-810 | - | - | - | - | 1件: 251 251 |
1375 | ARD-101 | - | - | - | - | 1件: 193 193 |
1376 | ARD-3150 | - | - | - | - | 1件: 299 299 |
1377 | Arg | - | - | - | - | 1件: 78 78 |
1378 | Arginin | - | - | - | - | 1件: 78 78 |
1379 | Arginina | 1件: Arginine Arginine | 1件: D02982
D02982
| - | - | 2件: 58 58, 78 |
1380 | ARGININA CLORIDRATO | 1件: Arginine Arginine | 1件: D02982
D02982
| - | - | 1件: 78 78 |
1381 | Arginine | 1件: Arginine Arginine | 1件: D02982
D02982
| - | - | 11件: 46 46, 58, 67, 78, 96, 97, 98, 113, 210, 251, 299 |
1382 | Arginine and Clonidine Stimulation Testing | 2件: Arginine Arginine, Clonidine | 3件: D00281
D00281
,
D00604
,
D02982
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 78 78 |
1383 | ARGININE HYDROCHLORIDE | 1件: Arginine Arginine | 1件: D02982
D02982
| - | - | 1件: 78 78 |
1384 | Arginine stimulation test after each limb | 1件: Arginine Arginine | 1件: D02982
D02982
| - | - | 1件: 78 78 |
1385 | Argininhydrochlorid | - | - | - | - | 1件: 65 65 |
1386 | ARGX-113 | - | - | - | - | 4件: 11 11, 14, 35, 63 |
1387 | ARGX-117 | - | - | - | - | 1件: 14 14 |
1388 | ARGX-117 IV | - | - | - | - | 1件: 14 14 |
1389 | ARICEPT | 1件: Donepezil Donepezil | 2件: D00670
D00670
,
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 4件: 6 6, 13, 78, 124 |
1390 | Aricept 10 mg | 1件: Donepezil Donepezil | 2件: D00670
D00670
,
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 13 13 |
1391 | Aricept 10 mg filmdragerade tabletter | 1件: Donepezil Donepezil | 2件: D00670
D00670
,
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 13 13 |
1392 | Aricept 5 mg | 1件: Donepezil Donepezil | 2件: D00670
D00670
,
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 13 13 |
1393 | Aricept 5 mg filmdragerade tabletter | 1件: Donepezil Donepezil | 2件: D00670
D00670
,
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 13 13 |
1394 | Aricept 5 mg-Filmtabletten | - | - | - | - | 1件: 6 6 |
1395 | ARICEPT 5*28 CPR 5 MG | 1件: Donepezil Donepezil | 2件: D00670
D00670
,
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 124 124 |
1396 | Aricept 5mg-Filmtabletten | - | - | - | - | 1件: 6 6 |
1397 | Aridol | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
1398 | Aridol or Osmohale | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
1399 | ARIKACE™ | - | - | - | - | 1件: 299 299 |
1400 | Arikayce | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
1401 | Arikayce™ | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
1402 | Arikayce™ 140 mg | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
1403 | Arikayce™ 560 mg | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
1404 | Arikayce™ 70 mg | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
1405 | Arimidex | 1件: Anastrozole Anastrozole | 1件: D00960
D00960
| 1件: CYP19A1 CYP19A1 💬 | 3件: Metabolic pathways Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬 | 1件: 78 78 |
1406 | Arimidex (Anastrozole) | 1件: Anastrozole Anastrozole | 1件: D00960
D00960
| 1件: CYP19A1 CYP19A1 💬 | 3件: Metabolic pathways Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬 | 1件: 78 78 |
1407 | ARIMOCLOMOL | 1件: Arimoclomol Arimoclomol | 1件: D11374
D11374
| - | - | 3件: 2 2, 15, 19 |
1408 | Arimoclomol (hard gelatine capsule) | 2件: Arimoclomol Arimoclomol, Gelatin | 3件: D00115
D00115
,
D06892
,
D11374
| - | - | 1件: 19 19 |
1409 | Arimoclomol (HPMC capsule) | 1件: Arimoclomol Arimoclomol | 1件: D11374
D11374
| - | - | 1件: 19 19 |
1410 | Arimoclomol citrate | 1件: Arimoclomol Arimoclomol | 1件: D11374
D11374
| - | - | 2件: 15 15, 19 |
1411 | Aripiprazole | 1件: Aripiprazole Aripiprazole | 1件: D01164
D01164
| 4件: DRD2 DRD2, DRD3, HTR1A, HTR2A 💬 | 12件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 2件: 6 6, 206 |
1412 | Arm 1 - GEH120714 (18F) Injection | - | - | - | - | 1件: 13 13 |
1413 | Arm B: Rituxan®/Mabthera® | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
1414 | Armodafinil | 1件: Armodafinil Armodafinil | 1件: D03215
D03215
| 1件: SLC6A3 SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 3件: 6 6, 13, 84 |
1415 | ARN-6039 | - | - | - | - | 1件: 13 13 |
1416 | ARO-AAT | - | - | - | - | 1件: 231 231 |
1417 | ARO-AAT Injection | - | - | - | - | 1件: 231 231 |
1418 | ARO-C3 | - | - | - | - | 2件: 62 62, 66 |
1419 | ARO-ENaC | - | - | - | - | 1件: 299 299 |
1420 | ARRY-371797 | - | - | - | - | 1件: 271 271 |
1421 | ARRY-371797, p38 inhibitor | - | - | - | - | 2件: 46 46, 271 |
1422 | ARRY-438162 | - | - | - | - | 1件: 46 46 |
1423 | ARRY-438162, MEK inhibitor | - | - | - | - | 1件: 46 46 |
1424 | ART-123 | - | - | - | - | 1件: 85 85 |
1425 | ART621 | - | - | - | - | 1件: 46 46 |
1426 | Artamin 150 mg | - | - | - | - | 1件: 171 171 |
1427 | Artamin 250 mg | - | - | - | - | 1件: 171 171 |
1428 | Artane | - | - | - | - | 1件: 6 6 |
1429 | Artesunate | 1件: Artesunate Artesunate | 1件: D02482
D02482
| - | - | 3件: 18 18, 66, 96 |
1430 | Artesunate Oral Product | 1件: Artesunate Artesunate | 1件: D02482
D02482
| - | - | 1件: 18 18 |
1431 | Arthroscopic synovectomy of the wrist | - | - | - | - | 1件: 46 46 |
1432 | Arthroscopic synovial tissue biopsy | - | - | - | - | 1件: 46 46 |
1433 | Arthroscopy & saline irrigation alone | - | - | - | - | 1件: 46 46 |
1434 | Artificial Saliva | - | - | - | - | 1件: 53 53 |
1435 | Artilog | - | - | - | - | 1件: 46 46 |
1436 | Arundic Acid | 1件: Arundic acid Arundic acid | 1件: D06296
D06296
| - | - | 1件: 2 2 |
1437 | ARX201 | 1件: ARX201 ARX201 | - | - | - | 1件: 78 78 |
1438 | Arylsulfatase A | - | - | - | - | 1件: 19 19 |
1439 | Arzerra | 1件: Ofatumumab Ofatumumab | 1件: D09314
D09314
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
1440 | ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI | 1件: Ofatumumab Ofatumumab | 1件: D09314
D09314
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
1441 | ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA | 1件: Ofatumumab Ofatumumab | 1件: D09314
D09314
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
1442 | Arzerra® | 1件: Ofatumumab Ofatumumab | 1件: D09314
D09314
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
1443 | AS | - | - | - | - | 6件: 46 46, 53, 96, 97, 215, 271 |
1444 | AS Domelock System | - | - | - | - | 1件: 46 46 |
1445 | AS INN | - | - | - | - | 1件: 97 97 |
1446 | AS2 | - | - | - | - | 1件: 6 6 |
1447 | ASA | - | - | - | - | 4件: 13 13, 96, 97, 251 |
1448 | ASACOL | - | - | - | - | 1件: 97 97 |
1449 | Asacol (mesalamine) | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
1450 | Asacol (mesalamine) Delayed-release Tablets | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
1451 | Asacol 400 mg | - | - | - | - | 1件: 97 97 |
1452 | Asacol 400 mg (mesalamine) | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
1453 | Asacol 400 mg tablet | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
1454 | Asacol 400mg tablet | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
1455 | Asacol 800 mg (mesalamine) | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
1456 | Asacol 800 mg tablet | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
1457 | Asacol 800mg tablet | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
1458 | Asacol Delayed Release Tablets | 2件: Manganese citrate Manganese citrate, Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
1459 | Asacol Delayed-Release Tablets | 2件: Manganese citrate Manganese citrate, Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
1460 | Asacol tablet | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
1461 | Asacol® | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
1462 | Asacol® 400 mg | - | - | - | - | 1件: 97 97 |
1463 | ASASANTIN Retard | - | - | - | - | 1件: 51 51 |
1464 | Asasantin Retard ® | - | - | - | - | 1件: 51 51 |
1465 | ASB-683699 | - | - | - | - | 1件: 13 13 |
1466 | ASC | - | - | - | - | 4件: 36 36, 51, 96, 97 |
1467 | ASC42 10 mg | - | - | - | - | 1件: 93 93 |
1468 | ASC42 15 mg | - | - | - | - | 1件: 93 93 |
1469 | ASC42 5 mg | - | - | - | - | 1件: 93 93 |
1470 | Ascal(r) / carbasalate calcium | 2件: Calcium Calcium, Carbaspirin calcium | 1件: D03385
D03385
| - | - | 1件: 46 46 |
1471 | Asceniv™ | - | - | - | - | 1件: 65 65 |
1472 | Ascorbic acid | 1件: Ascorbic acid Ascorbic acid | 1件: D00018
D00018
| - | - | 4件: 10 10, 97, 206, 298 |
1473 | Ascorbic acid (Vitamin C) | 1件: Ascorbic acid Ascorbic acid | 1件: D00018
D00018
| - | - | 1件: 10 10 |
1474 | Ascorbic Acid (Vitamin C) and Alpha-tocopherol (Vitamin E) | 3件: Ascorbic acid Ascorbic acid, Tocopherol, Vitamin E | 3件: D00018
D00018
,
D02331
,
D02332
| - | - | 1件: 206 206 |
1475 | Ascorbic acid vit C | 1件: Ascorbic acid Ascorbic acid | 1件: D00018
D00018
| - | - | 1件: 10 10 |
1476 | ASCs | - | - | - | - | 2件: 53 53, 96 |
1477 | ASCs: Adipose derived Stem Cells | - | - | - | - | 1件: 96 96 |
1478 | Asendis | - | - | - | - | 1件: 46 46 |
1479 | Asendis 50 mg | - | - | - | - | 1件: 46 46 |
1480 | ASF-1096 Cream 0.25% | - | - | - | - | 1件: 49 49 |
1481 | ASF-1096 Cream 0.5% | - | - | - | - | 1件: 49 49 |
1482 | ASF-1096 Cream 1.0% | - | - | - | - | 1件: 49 49 |
1483 | Asfotas Alfa | - | - | - | - | 1件: 172 172 |
1484 | ASFOTASE ALFA | 1件: Asfotase alfa Asfotase alfa | 1件: D10595
D10595
| 1件: ALPL ALPL 💬 | 4件: Biosynthesis of cofactors Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism 💬 | 1件: 172 172 |
1485 | Asfotase Alfa (ALXN1215) | 1件: Asfotase alfa Asfotase alfa | 1件: D10595
D10595
| 1件: ALPL ALPL 💬 | 4件: Biosynthesis of cofactors Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism 💬 | 1件: 172 172 |
1486 | ASK Nr. 21972 | - | - | - | - | 1件: 5 5 |
1487 | ASK8007 | - | - | - | - | 1件: 46 46 |
1488 | ASP015K | - | - | - | - | 2件: 46 46, 97 |
1489 | ASP015K hydrobromide | - | - | - | - | 1件: 46 46 |
1490 | ASP015K hydrobromide, AS1940150-BR, JKT-201A, 4-{[(1R,2s,3S,5s,7s)-5-Hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-b]pyridine-5-carboxamide monohydrobromide | - | - | - | - | 1件: 46 46 |
1491 | ASP1707 | - | - | - | - | 1件: 46 46 |
1492 | ASP2408 | - | - | - | - | 1件: 46 46 |
1493 | ASP2409 | - | - | - | - | 1件: 46 46 |
1494 | ASP3291 | - | - | - | - | 1件: 97 97 |
1495 | ASP3652 | - | - | - | - | 1件: 226 226 |
1496 | ASP5094 | - | - | - | - | 1件: 46 46 |
1497 | ASP6294 | - | - | - | - | 1件: 226 226 |
1498 | Asparaginase | 1件: Asparaginase Escherichia coli Asparaginase Escherichia coli | 1件: D02997
D02997
| - | - | 1件: 65 65 |
1499 | Aspergillus oryzae | 1件: Aspergillus oryzae Aspergillus oryzae | - | - | - | 1件: 97 97 |
1500 | Aspirin | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: D00109
D00109
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 12件: 13 13, 22, 34, 46, 49, 51, 58, 86, 113, 158, 210, 231 |
1501 | Aspirin 650mg Oral Capsule | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: D00109
D00109
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 |
1502 | Aspirin 81mg tablet | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: D00109
D00109
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
1503 | Aspirin and meloxicam | 2件: Acetylsalicylic acid Acetylsalicylic acid, Meloxicam | 2件: D00109
D00109
,
D00969
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 49 49 |
1504 | Aspirin Tablets | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: D00109
D00109
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
1505 | Assessment of therapy complications | - | - | - | - | 1件: 60 60 |
1506 | Assigned Interventions CD19/BCMA CAR T-cells | - | - | - | - | 3件: 49 49, 51, 53 |
1507 | Assigned pulmonary hypertension medication | - | - | - | - | 1件: 86 86 |
1508 | AST-120 | - | - | - | - | 2件: 96 96, 97 |
1509 | AstroRx | - | - | - | - | 1件: 2 2 |
1510 | ASyn Mab | - | - | - | - | 1件: 6 6 |
1511 | AT 10 | - | - | - | - | 2件: 6 6, 85 |
1512 | AT-1501 | - | - | - | - | 2件: 2 2, 66 |
1513 | AT-GTX-501 | - | - | - | - | 1件: 19 19 |
1514 | AT1-inhibitor | - | - | - | - | 1件: 218 218 |
1515 | AT1001 | - | - | - | - | 1件: 19 19 |
1516 | AT1001 150 mg | - | - | - | - | 1件: 19 19 |
1517 | AT132 | - | - | - | - | 1件: 111 111 |
1518 | AT2101 | - | - | - | - | 1件: 19 19 |
1519 | AT2220 | 1件: AT2220 AT2220 | - | - | - | 1件: 256 256 |
1520 | AT2221 | - | - | - | - | 1件: 256 256 |
1521 | AT2221 65 mg Formulated Capsules | - | - | - | - | 1件: 256 256 |
1522 | AT845 | - | - | - | - | 1件: 256 256 |
1523 | ATA188 | - | - | - | - | 1件: 13 13 |
1524 | Atacicept | 1件: Atacicept Atacicept | 1件: D09704
D09704
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 4件: 13 13, 46, 49, 66 |
1525 | Atacicept 150 mg | 1件: Atacicept Atacicept | 1件: D09704
D09704
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 2件: 13 13, 49 |
1526 | Atacicept 25 mg | 1件: Atacicept Atacicept | 1件: D09704
D09704
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 2件: 13 13, 66 |
1527 | Atacicept 75 mg | 1件: Atacicept Atacicept | 1件: D09704
D09704
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 3件: 13 13, 49, 66 |
1528 | Atacicept 75 milligram (mg) | 1件: Atacicept Atacicept | 1件: D09704
D09704
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 49 49 |
1529 | Atacicept150mg | - | - | - | - | 1件: 66 66 |
1530 | Atacicept25mg | - | - | - | - | 1件: 66 66 |
1531 | Atacicept75mg | - | - | - | - | 1件: 66 66 |
1532 | Atacicept: with loading dose | 1件: Atacicept Atacicept | 1件: D09704
D09704
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 46 46 |
1533 | ATALUREN | 1件: Ataluren Ataluren | 1件: D09323
D09323
| - | - | 6件: 19 19, 113, 140, 246, 299, 329 |
1534 | Ataluren (PTC124®) | 1件: Ataluren Ataluren | 1件: D09323
D09323
| - | - | 1件: 299 299 |
1535 | Ataluren 1000 mg | 1件: Ataluren Ataluren | 1件: D09323
D09323
| - | - | 1件: 113 113 |
1536 | Ataluren 1000mg | 1件: Ataluren Ataluren | 1件: D09323
D09323
| - | - | 1件: 246 246 |
1537 | Ataluren 125 mg | 1件: Ataluren Ataluren | 1件: D09323
D09323
| - | - | 1件: 113 113 |
1538 | Ataluren 125mg | 1件: Ataluren Ataluren | 1件: D09323
D09323
| - | - | 1件: 246 246 |
1539 | Ataluren 250 mg | 1件: Ataluren Ataluren | 1件: D09323
D09323
| - | - | 1件: 113 113 |
1540 | Ataluren 250mg | 1件: Ataluren Ataluren | 1件: D09323
D09323
| - | - | 1件: 246 246 |
1541 | Atazanavir | 1件: Atazanavir Atazanavir | 2件: D01276
D01276
,
D07471
| - | - | 1件: 265 265 |
1542 | Atazanavir (ATV) + ritonavir (RTV), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (NRTIs) | 2件: Atazanavir Atazanavir, Ritonavir | 3件: D00427
D00427
,
D01276
,
D07471
| - | - | 1件: 265 265 |
1543 | Atazanavir (Reyataz) | 1件: Atazanavir Atazanavir | 2件: D01276
D01276
,
D07471
| - | - | 1件: 265 265 |
1544 | Atazanavir/Ritonavir | 2件: Atazanavir Atazanavir, Ritonavir | 3件: D00427
D00427
,
D01276
,
D07471
| - | - | 1件: 265 265 |
1545 | ATB200 | - | - | - | - | 1件: 256 256 |
1546 | ATENOLOL | 1件: Atenolol Atenolol | 1件: D00235
D00235
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 167 167 |
1547 | Atenolol or Propranolol | 2件: Atenolol Atenolol, Propranolol | 3件: D00235
D00235
,
D00483
,
D08443
| 3件: ADRB1 ADRB1, ADRB2, ADRB3 💬 | 12件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 167 167 |
1548 | Atezolizumab | 1件: Atezolizumab Atezolizumab | 1件: D10773
D10773
| 1件: CD274 CD274 💬 | 2件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | 1件: 85 85 |
1549 | ATG | - | - | - | - | 4件: 13 13, 60, 96, 285 |
1550 | ATG (rabbit) | 1件: Rabbit Rabbit | - | - | - | 1件: 11 11 |
1551 | ATG conditioning regimen | - | - | - | - | 1件: 60 60 |
1552 | ATG+cyclosporine | 1件: Cyclosporine Cyclosporine | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 60 60 |
1553 | ATG+Rapamune+cyclosporine | 1件: Cyclosporine Cyclosporine | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 60 60 |
1554 | ATG-F | - | - | - | - | 1件: 66 66 |
1555 | ATG-Fresenius | - | - | - | - | 1件: 60 60 |
1556 | Atgam | 1件: Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | - | - | - | 1件: 60 60 |
1557 | ATGAM plus CsA with or without Eltrombopag | 1件: Eltrombopag Eltrombopag | - | - | - | 1件: 60 60 |
1558 | ATH-1017 | - | - | - | - | 1件: 6 6 |
1559 | ATH434 dose level 1 | - | - | - | - | 1件: 17 17 |
1560 | ATH434 dose level 2 | - | - | - | - | 1件: 17 17 |
1561 | ATI-450 | - | - | - | - | 2件: 46 46, 106 |
1562 | ATL-2502 | 1件: ATL-2502 ATL-2502 | - | - | - | 1件: 97 97 |
1563 | ATL1102 | 1件: ATL1102 ATL1102 | - | - | - | 1件: 13 13 |
1564 | ATM FOG in PD | - | - | - | - | 1件: 6 6 |
1565 | ATN-103 | - | - | - | - | 1件: 46 46 |
1566 | ATN-103 10 mg q4wks | - | - | - | - | 1件: 46 46 |
1567 | ATN-103 10 mg q8wks | - | - | - | - | 1件: 46 46 |
1568 | ATN-103 30 mg q4wks | - | - | - | - | 1件: 46 46 |
1569 | ATN-103 80 mg q4wks | - | - | - | - | 1件: 46 46 |
1570 | ATN-103 80 mg q8wks | - | - | - | - | 1件: 46 46 |
1571 | Atomexetine | - | - | - | - | 1件: 17 17 |
1572 | Atomoxetine | 1件: Atomoxetine Atomoxetine | 2件: D02574
D02574
,
D07473
| 1件: SLC6A2 SLC6A2 💬 | 1件: Synaptic vesicle cycle Synaptic vesicle cycle 💬 | 4件: 6 6, 8, 13, 17 |
1573 | Atorvastatin | 1件: Atorvastatin Atorvastatin | 3件: D00258
D00258
,
D00887
,
D07474
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 18件: 13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 299 |
1574 | Atorvastatin 10mg | 1件: Atorvastatin Atorvastatin | 3件: D00258
D00258
,
D00887
,
D07474
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 63 63 |
1575 | Atorvastatin 20mg | 1件: Atorvastatin Atorvastatin | 3件: D00258
D00258
,
D00887
,
D07474
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 63 63 |
1576 | Atorvastatin Calcium | 2件: Atorvastatin Atorvastatin, Calcium | 3件: D00258
D00258
,
D00887
,
D07474
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 2件: 97 97, 265 |
1577 | Atorvastatin tablet 20 mg | 1件: Atorvastatin Atorvastatin | 3件: D00258
D00258
,
D00887
,
D07474
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 46 46 |
1578 | Atosiban | 1件: Atosiban Atosiban | 1件: D03008
D03008
| 1件: OXTR OXTR 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 1件: 118 118 |
1579 | ATOVAQUONE | 1件: Atovaquone Atovaquone | 1件: D00236
D00236
| - | - | 1件: 61 61 |
1580 | ATR-101 | - | - | - | - | 2件: 75 75, 81 |
1581 | ATRA | 1件: Tretinoin Tretinoin | 1件: D00094
D00094
| 3件: PML PML, RARA, RARB 💬 | 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 2件: 63 63, 94 |
1582 | ATRASENTAN | 1件: Atrasentan Atrasentan | - | - | - | 3件: 66 66, 218, 222 |
1583 | Atropina | 1件: Atropine Atropine | 5件: D00113
D00113
,
D01077
,
D02069
,
D03011
,
D03814
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 299 299 |
1584 | Atropine | 1件: Atropine Atropine | 5件: D00113
D00113
,
D01077
,
D02069
,
D03011
,
D03814
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 2 2 |
1585 | ATV | - | - | - | - | 1件: 265 265 |
1586 | ATX-MS-1467 | - | - | - | - | 1件: 13 13 |
1587 | Atypical Antipsychotics | - | - | - | - | 1件: 6 6 |
1588 | ATYR1923 | 1件: ATYR1923 ATYR1923 | - | - | - | 1件: 84 84 |
1589 | ATYR1923 1.0 mg/kg | 1件: ATYR1923 ATYR1923 | - | - | - | 1件: 84 84 |
1590 | ATYR1923 3.0 mg/kg | 1件: ATYR1923 ATYR1923 | - | - | - | 1件: 84 84 |
1591 | ATYR1923 5.0 mg/kg | 1件: ATYR1923 ATYR1923 | - | - | - | 1件: 84 84 |
1592 | ATYR1940 | - | - | - | - | 1件: 113 113 |
1593 | AUBAGIO | 1件: Teriflunomide Teriflunomide | 1件: D10172
D10172
| 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 13 13 |
1594 | AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BISTER (ALU/ALU) PERFORATO MONODOSE - 10 X 1 COMPRESSA | 1件: Teriflunomide Teriflunomide | 1件: D10172
D10172
| 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 13 13 |
1595 | AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (ALU/ALU) - 28 COMPRESSE | 1件: Teriflunomide Teriflunomide | 1件: D10172
D10172
| 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 13 13 |
1596 | Aubagio 14 mg film-coated tablets | 1件: Teriflunomide Teriflunomide | 1件: D10172
D10172
| 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 13 13 |
1597 | Aubagio® | 1件: Teriflunomide Teriflunomide | 1件: D10172
D10172
| 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 13 13 |
1598 | AUC of MPA measure | - | - | - | - | 1件: 51 51 |
1599 | Audiological and ear, nose and throat examination | - | - | - | - | 1件: 78 78 |
1600 | Augmentin | 1件: Clavulanic acid Clavulanic acid | 1件: D07711
D07711
| - | - | 1件: 299 299 |
1601 | Aurexis | - | - | - | - | 1件: 299 299 |
1602 | Aurexis® (tefibazumab) | 1件: Tefibazumab Tefibazumab | 1件: D06054
D06054
| - | - | 1件: 299 299 |
1603 | Auto Injector | - | - | - | - | 1件: 46 46 |
1604 | Auto-Injector Device (AID) | - | - | - | - | 1件: 46 46 |
1605 | Auto-titrating oxygen system | 1件: Oxygen Oxygen | 1件: D00003
D00003
| - | - | 1件: 85 85 |
1606 | Autoantibody Reductive Therapy | - | - | - | - | 1件: 85 85 |
1607 | Autofluorescent detection + Injection of indocyanine green | 1件: Indocyanine green Indocyanine green | 1件: D01342
D01342
| - | - | 1件: 235 235 |
1608 | Autoinjector | - | - | - | - | 1件: 46 46 |
1609 | Autologous (self) mononuclear cells derived from umbilical cord blood | - | - | - | - | 1件: 211 211 |
1610 | Autologous adipose derived mesenchymal cells | - | - | - | - | 1件: 13 13 |
1611 | Autologous Adipose Derived MSCs (ADMSCs) | - | - | - | - | 1件: 85 85 |
1612 | Autologous adipose derived stem cells | - | - | - | - | 1件: 46 46 |
1613 | Autologous ADIpose derived stromal vascular fraction | - | - | - | - | 1件: 96 96 |
1614 | Autologous Adipose Mesenchymal Stem Cell Implantation | - | - | - | - | 1件: 17 17 |
1615 | Autologous Adipose-derived Mesenchymal Stromal Cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 2 2 |
1616 | Autologous adult bone marrow mononuclear cells (BM-MNC) unexpanded | - | - | - | - | 1件: 2 2 |
1617 | Autologous adult bone marrow mononuclear cells unexpanded | - | - | - | - | 1件: 2 2 |
1618 | Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved | - | - | - | - | 1件: 13 13 |
1619 | Autologous apoptotic cells injection | - | - | - | - | 1件: 46 46 |
1620 | Autologous ASC | - | - | - | - | 1件: 51 51 |
1621 | Autologous bone marrow mononuclear cell transplantation | - | - | - | - | 1件: 113 113 |
1622 | Autologous bone marrow mononucleated cells | - | - | - | - | 1件: 2 2 |
1623 | Autologous bone marrow transplantation | - | - | - | - | 2件: 13 13, 28 |
1624 | Autologous Bone Marrow-Derived Mononuclear Stem Cells | - | - | - | - | 1件: 13 13 |
1625 | Autologous bone marrow-derived stem cells | - | - | - | - | 1件: 2 2 |
1626 | Autologous CD34+ cell transduced with G2SCID vector | - | - | - | - | 1件: 65 65 |
1627 | AUTOLOGOUS CD34+ CELLS TRANSDUCED EX-VIVO WITH THE PCCLCHIMGP91/VSVG LENTIVIRAL VECTOR | - | - | - | - | 1件: 65 65 |
1628 | AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING THE HUMAN SGSH GENE | - | - | - | - | 1件: 19 19 |
1629 | Autologous CD34+ cells transduced with a lentiviral vector encoding the ARSA cDNA | - | - | - | - | 1件: 19 19 |
1630 | AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH LENTI-D VECTOR ENCODING ABCD1 CDNA | - | - | - | - | 1件: 20 20 |
1631 | Autologous CD34+ cells transduced with the Lentiviral vector containing the human Wiskott Aldrich Sy | - | - | - | - | 1件: 65 65 |
1632 | Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with lentiviral vector that encodes for the human Wiskott Aldrich Syndrome (WAS) cDNA sequence | - | - | - | - | 1件: 65 65 |
1633 | Autologous CD34+ HSCs transduced ex vivo with EFS lentiviral vector encoding for the human ADA gene | - | - | - | - | 1件: 65 65 |
1634 | AUTOLOGOUS CD34+CELLS TRANSDUCED WITH THE W1.6_HWASP_WPRE (VSVG) LENTIVIRAL VECTOR | - | - | - | - | 1件: 65 65 |
1635 | Autologous CD34+HPC transplantation (HSCT) | - | - | - | - | 1件: 49 49 |
1636 | Autologous CD34-selected peripheral blood stem cells transplant | - | - | - | - | 1件: 96 96 |
1637 | Autologous CD4+T cells stimulated and expanded ex vivo by a MOG peptide modified by the introduction of a thioreductase motif into the flanking residues of the T cell epitope | - | - | - | - | 1件: 13 13 |
1638 | Autologous cell-based delivery | - | - | - | - | 1件: 211 211 |
1639 | Autologous EBV specific CTL infusion | - | - | - | - | 1件: 49 49 |
1640 | Autologous EPCs transfected | - | - | - | - | 1件: 86 86 |
1641 | Autologous EPCs transfected with human eNOS | - | - | - | - | 1件: 86 86 |
1642 | Autologous ex vivo gene therapy products based on the EFS LV encoding for the human adenosine deaminase (ADA) gene (EFS-ADA LV) | 1件: Adenosine Adenosine | 1件: D00045
D00045
| 4件: ADORA1 ADORA1, ADORA2A, ADORA2B, ADORA3 💬 | 12件: Alcoholism Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 |
1643 | Autologous haematopoietic stem cells transduced with lentiviral vector Lenti-D encoding the human ABCD1 cDNA | - | - | - | - | 1件: 20 20 |
1644 | Autologous Hematopoietic Stem Cell | - | - | - | - | 1件: 13 13 |
1645 | Autologous hematopoietic stem cell transplant | - | - | - | - | 1件: 13 13 |
1646 | Autologous Hematopoietic Stem Cell Transplantation | - | - | - | - | 7件: 11 11, 13, 14, 28, 49, 51, 84 |
1647 | Autologous hematopoietic stem cell transplantation (ASCT) | - | - | - | - | 1件: 28 28 |
1648 | Autologous hematopoietic stem cells | - | - | - | - | 1件: 13 13 |
1649 | Autologous Human Placental Cord Blood Mononuclear Cells | - | - | - | - | 1件: 211 211 |
1650 | Autologous mature tolerogenic monocyte-derived Dendritic Cells loaded with the B29 peptide of HSP70 | - | - | - | - | 1件: 46 46 |
1651 | Autologous Mesenchymal Cell Product | - | - | - | - | 1件: 13 13 |
1652 | Autologous mesenchymal stem cell transplantation | - | - | - | - | 1件: 13 13 |
1653 | Autologous mesenchymal stem cells | - | - | - | - | 5件: 2 2, 6, 13, 17, 46 |
1654 | Autologous Mesenchymal stem cells (MSCs) | - | - | - | - | 1件: 2 2 |
1655 | Autologous mesenchymal stem cells derived from bone marrow | - | - | - | - | 1件: 85 85 |
1656 | Autologous mesenchymal stromal cell | - | - | - | - | 2件: 96 96, 298 |
1657 | Autologous MSC-NTF cells | - | - | - | - | 1件: 2 2 |
1658 | Autologous ovalbumin-specific type 1 regulatory T lymphocytes expanded population | - | - | - | - | 1件: 96 96 |
1659 | Autologous peripheral blood stem cell transplantation | - | - | - | - | 8件: 28 28, 40, 41, 42, 45, 46, 49, 283 |
1660 | Autologous Plasmablasts | - | - | - | - | 1件: 19 19 |
1661 | Autologous Regulatory ?-cells | - | - | - | - | 1件: 51 51 |
1662 | Autologous serum | - | - | - | - | 1件: 53 53 |
1663 | Autologous Serum 20% | - | - | - | - | 1件: 53 53 |
1664 | Autologous Serum 50% | - | - | - | - | 1件: 53 53 |
1665 | Autologous Stem Cell | - | - | - | - | 1件: 8 8 |
1666 | Autologous stem cell transplant | - | - | - | - | 4件: 28 28, 53, 56, 96 |
1667 | Autologous Stem Cell Transplantation | - | - | - | - | 4件: 13 13, 28, 56, 96 |
1668 | Autologous Stem Cells | - | - | - | - | 2件: 13 13, 51 |
1669 | Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells | - | - | - | - | 1件: 51 51 |
1670 | Autologous Stromal Vascular Fraction (SVF) | - | - | - | - | 1件: 85 85 |
1671 | Autologous stromal vascular fraction cells | - | - | - | - | 1件: 46 46 |
1672 | AUTOLOGOUS T-LYMPHOCYTES | - | - | - | - | 1件: 13 13 |
1673 | Autologous T-regulatory lymphocytes | - | - | - | - | 1件: 2 2 |
1674 | Autologous Tissue-Engineered Vascular Graft | - | - | - | - | 1件: 210 210 |
1675 | Autologous Umbilical Cord Blood | - | - | - | - | 2件: 211 211, 294 |
1676 | Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (tolDC-VitD3) | - | - | - | - | 1件: 13 13 |
1677 | Autologous-autologous tandem hematopoietic stem cell transplantation | - | - | - | - | 1件: 28 28 |
1678 | Automated abdominal binder | - | - | - | - | 1件: 17 17 |
1679 | AV-101 | 1件: AV-101 AV-101 | - | - | - | 2件: 6 6, 86 |
1680 | AV1451 Tau | - | - | - | - | 1件: 127 127 |
1681 | AV605 | - | - | - | - | 1件: 13 13 |
1682 | Avacincaptad pegol | 1件: Avacincaptad pegol Avacincaptad pegol | - | - | - | 1件: 301 301 |
1683 | Avacopan | 1件: Avacopan Avacopan | 1件: D11093
D11093
| 1件: C5AR1 C5AR1 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Staphylococcus aureus infection 💬 | 3件: 43 43, 44, 222 |
1684 | Avalglucosidase Alfa | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: D11744
D11744
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
1685 | Avalglucosidase alfa (GZ402666) | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: D11744
D11744
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
1686 | Avalglucosidase Alfa (NeoGAA) | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: D11744
D11744
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
1687 | Avalglucosidase alfa GZ402666 | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: D11744
D11744
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
1688 | Avalglucosidase alfa(GZ402666) | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: D11744
D11744
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
1689 | Avalglucosidasi alfa | - | - | - | - | 1件: 256 256 |
1690 | AVALOX - 400 | - | - | - | - | 1件: 6 6 |
1691 | Avandia administration for 6-12 weeks | - | - | - | - | 1件: 265 265 |
1692 | AVASTIN | 1件: Bevacizumab Bevacizumab | 1件: D06409
D06409
| 1件: VEGFA VEGFA 💬 | 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 1件: 227 227 |
1693 | AVASTIN 25 mg/ml - Konzentrat zur Herstellung einer Infusionsloesung | 1件: Bevacizumab Bevacizumab | 1件: D06409
D06409
| 1件: VEGFA VEGFA 💬 | 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 1件: 227 227 |
1694 | Avatrombopag | 1件: Avatrombopag Avatrombopag | 1件: D10306
D10306
| 1件: MPL MPL 💬 | 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 2件: 60 60, 63 |
1695 | Avatrombopag (proposed) | 1件: Avatrombopag Avatrombopag | 1件: D10306
D10306
| 1件: MPL MPL 💬 | 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 1件: 63 63 |
1696 | Avatrombopag 20 MG | 1件: Avatrombopag Avatrombopag | 1件: D10306
D10306
| 1件: MPL MPL 💬 | 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 1件: 60 60 |
1697 | AVATROMBOPAG MALEATE | 1件: Avatrombopag Avatrombopag | 1件: D10306
D10306
| 1件: MPL MPL 💬 | 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 1件: 63 63 |
1698 | Avatrombopag tablets | 1件: Avatrombopag Avatrombopag | 1件: D10306
D10306
| 1件: MPL MPL 💬 | 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 1件: 63 63 |
1699 | AVB-114 | - | - | - | - | 1件: 96 96 |
1700 | AVB-S6-500 | - | - | - | - | 1件: 66 66 |
1701 | AVCN583601 (3% Cannabidiol cream) | 1件: Cannabidiol Cannabidiol | 1件: D10915
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 36 36 |
1702 | Avdoralimab | 1件: Avdoralimab Avdoralimab | - | - | - | 1件: 162 162 |
1703 | Avdoralimab (IPH5401) | 1件: Avdoralimab Avdoralimab | - | - | - | 1件: 162 162 |
1704 | AVE8112 | - | - | - | - | 1件: 6 6 |
1705 | AVE9897 | - | - | - | - | 1件: 46 46 |
1706 | Avelox- Moxifloxacin | 1件: Moxifloxacin Moxifloxacin | 2件: D00874
D00874
,
D08237
| - | - | 1件: 46 46 |
1707 | Avelox® | 1件: Moxifloxacin Moxifloxacin | 2件: D00874
D00874
,
D08237
| - | - | 1件: 46 46 |
1708 | AVI-4658 | - | - | - | - | 1件: 113 113 |
1709 | AVI-4658 (Eteplirsen) | 1件: Eteplirsen Eteplirsen | 1件: D09900
D09900
| 1件: DMD DMD 💬 | 4件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 |
1710 | AVI-4658 (PMO) | - | - | - | - | 1件: 113 113 |
1711 | AVI-4658 for Injection | - | - | - | - | 1件: 113 113 |
1712 | Avian polyclonal IgY antibody against PA | - | - | - | - | 1件: 299 299 |
1713 | Avibactam | 1件: Avibactam Avibactam | - | - | - | 1件: 299 299 |
1714 | AVID200 | - | - | - | - | 1件: 51 51 |
1715 | Aviptadil | 1件: Aviptadil Aviptadil | 1件: D12127
D12127
| - | - | 5件: 49 49, 51, 84, 85, 86 |
1716 | Aviptadil, 66 microgram/mL | 1件: Aviptadil Aviptadil | 1件: D12127
D12127
| - | - | 1件: 85 85 |
1717 | AVONEX | 1件: Interferon beta-1a Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 2件: 13 13, 97 |
1718 | Avonex (Interferon beta 1a) | 2件: Human interferon beta Human interferon beta, Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
1719 | Avonex (interferon beta-1a), Biogen Idec Ltd | 2件: Human interferon beta Human interferon beta, Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
1720 | AVONEX - 30 MCG (6 MILIONI UI) POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 4 FLACONI CON DISPOSITIVO BIOSET + 4 SIRINGHE PRERIEMPITE USO INTRAMUSCOLARE | 1件: Interferon beta-1a Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
1721 | Avonex 30 microgram/0.5 ml Solution for Injection | 1件: Interferon beta-1a Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
1722 | AVONEX 30 microgramos/0,5 ml (Interferón Beta - 1a) Solución inyectable | 1件: Interferon beta-1a Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
1723 | Avonex 30 microgramos/0.5 ml Solución para inyección | 1件: Interferon beta-1a Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
1724 | AVONEX 30 µg/0,5 ml solution for injection | 1件: Interferon beta-1a Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
1725 | Avonex and Topamax | 1件: Interferon beta-1a Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
1726 | AVONEX IM 4SIR 30MCG/0,5ML 4AG | 1件: Interferon beta-1a Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
1727 | Avonex prefilled syringe via manual IM injection | 1件: Interferon beta-1a Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
1728 | AVONEX*IM 4SIR 30MCG/0,5ML+4AG | 1件: Interferon beta-1a Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
1729 | Avonex/Betaseron/Copaxone/Rebif | 3件: Glatiramer Glatiramer, Interferon beta-1a, Interferon beta-1b | 3件: D00746
D00746
,
D04318
,
D04554
| 22件: HLA-A HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, IFNAR1, IFNAR2 💬 | 44件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 |
1730 | Avonex/Zocor | 1件: Interferon beta-1a Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
1731 | AVONEX® | 1件: Interferon beta-1a Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
1732 | Avonex® monotherapy (6.0 MIU administered i.m. each week) | 1件: Interferon beta-1a Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
1733 | AVP-923 | - | - | - | - | 3件: 2 2, 6, 13 |
1734 | AVP-923-45 | - | - | - | - | 1件: 6 6 |
1735 | AVR-RD-01 | - | - | - | - | 1件: 19 19 |
1736 | AVR-RD-02 | - | - | - | - | 1件: 19 19 |
1737 | AVX 470 | - | - | - | - | 1件: 97 97 |
1738 | AVXS-101 | - | - | - | - | 1件: 3 3 |
1739 | AVXS-101 (previously known as scAAV9.CB.SMN) | - | - | - | - | 1件: 3 3 |
1740 | AX | - | - | - | - | 1件: 19 19 |
1741 | AX 250 | - | - | - | - | 1件: 19 19 |
1742 | Axially Oscillating Sphere dry powder inhaler (AOS DPI) | - | - | - | - | 1件: 86 86 |
1743 | Axitinib | 1件: Axitinib Axitinib | 1件: D03218
D03218
| 3件: FLT1 FLT1, FLT4, KDR 💬 | 15件: Breast cancer Breast cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Rheumatoid arthritis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 34 34 |
1744 | AXO-AAV-GM2 High Dose | - | - | - | - | 1件: 19 19 |
1745 | AXO-AAV-GM2 Low Dose | - | - | - | - | 1件: 19 19 |
1746 | AXO-AAV-GM2 Middle Dose | - | - | - | - | 1件: 19 19 |
1747 | AXO-AAV-GM2 Starting Dose | - | - | - | - | 1件: 19 19 |
1748 | AZA | - | - | - | - | 4件: 11 11, 40, 96, 97 |
1749 | AZA capsules | - | - | - | - | 1件: 96 96 |
1750 | AZAFOR - 50 MG COMPRESSE RIVESTITE CON FILM 50 COMPRESSE IN BLISTER PVC/PVDC/AL | - | - | - | - | 1件: 97 97 |
1751 | AZAFOR 50mg | - | - | - | - | 1件: 97 97 |
1752 | AZAPRED | - | - | - | - | 1件: 85 85 |
1753 | Azathioprin | - | - | - | - | 2件: 46 46, 96 |
1754 | Azathioprin-ratiopharm 25 mg | - | - | - | - | 1件: 96 96 |
1755 | Azathioprin-ratiopharm 25mg Filmtabletten | - | - | - | - | 1件: 96 96 |
1756 | Azathioprin-ratiopharm 50 mg Filmtabletten | - | - | - | - | 1件: 96 96 |
1757 | Azathioprin-ratiopharm® 25 mg Filmtabletten | - | - | - | - | 1件: 44 44 |
1758 | Azathioprine | 1件: Azathioprine Azathioprine | 2件: D00238
D00238
,
D03033
| - | - | 21件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 |
1759 | Azathioprine (AZA) | 1件: Azathioprine Azathioprine | 2件: D00238
D00238
,
D03033
| - | - | 3件: 13 13, 19, 97 |
1760 | Azathioprine (AZA) caps | 1件: Azathioprine Azathioprine | 2件: D00238
D00238
,
D03033
| - | - | 1件: 96 96 |
1761 | Azathioprine (AZA) or 6-mercaptopurine (6-MP) | 2件: Azathioprine Azathioprine, Mercaptopurine | 4件: D00161
D00161
,
D00238
,
D03033
,
D04931
| 1件: HPRT1 HPRT1 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 2件: 96 96, 97 |
1762 | Azathioprine (Imuran) 50 mg Overencapsulated Tablet | 1件: Azathioprine Azathioprine | 2件: D00238
D00238
,
D03033
| - | - | 1件: 97 97 |
1763 | Azathioprine - ratiopharm 50 mg | 1件: Azathioprine Azathioprine | 2件: D00238
D00238
,
D03033
| - | - | 1件: 96 96 |
1764 | Azathioprine / 6 Mercaptopurine | 2件: Azathioprine Azathioprine, Mercaptopurine | 4件: D00161
D00161
,
D00238
,
D03033
,
D04931
| 1件: HPRT1 HPRT1 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 96 96 |
1765 | Azathioprine 25 mg | 1件: Azathioprine Azathioprine | 2件: D00238
D00238
,
D03033
| - | - | 1件: 44 44 |
1766 | Azathioprine and Allopurinol | 2件: Allopurinol Allopurinol, Azathioprine | 3件: D00224
D00224
,
D00238
,
D03033
| 1件: XDH XDH 💬 | 5件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬 | 1件: 97 97 |
1767 | AZATHIOPRINE BP | 1件: Azathioprine Azathioprine | 2件: D00238
D00238
,
D03033
| - | - | 1件: 97 97 |
1768 | Azathioprine in case of endoscopic recurrence | 1件: Azathioprine Azathioprine | 2件: D00238
D00238
,
D03033
| - | - | 1件: 96 96 |
1769 | Azathioprine individualised dose | 1件: Azathioprine Azathioprine | 2件: D00238
D00238
,
D03033
| - | - | 1件: 96 96 |
1770 | Azathioprine or 6-mercaptopurine | 2件: Azathioprine Azathioprine, Mercaptopurine | 4件: D00161
D00161
,
D00238
,
D03033
,
D04931
| 1件: HPRT1 HPRT1 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 2件: 96 96, 97 |
1771 | Azathioprine or adalimumab and infliximab | 3件: Adalimumab Adalimumab, Azathioprine, Infliximab | 4件: D00238
D00238
,
D02597
,
D02598
,
D03033
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
1772 | Azathioprine OR Mesalazine | 2件: Azathioprine Azathioprine, Mesalazine | 3件: D00238
D00238
,
D00377
,
D03033
| - | - | 1件: 96 96 |
1773 | AZATHIOPRINE or METHOTREXATE | 2件: Azathioprine Azathioprine, Methotrexate | 4件: D00142
D00142
,
D00238
,
D02115
,
D03033
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 96 96 |
1774 | Azathioprine or Mycophenolate mofetil | 3件: Azathioprine Azathioprine, Mycophenolate mofetil, Mycophenolic acid | 6件: D00238
D00238
,
D00752
,
D03033
,
D05094
,
D05095
,
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 162 162 |
1775 | Azathioprine weight-based dose | 1件: Azathioprine Azathioprine | 2件: D00238
D00238
,
D03033
| - | - | 1件: 96 96 |
1776 | Azathioprine+enteral nutrition | 1件: Azathioprine Azathioprine | 2件: D00238
D00238
,
D03033
| - | - | 1件: 96 96 |
1777 | Azathioprine/prednisone | 2件: Azathioprine Azathioprine, Prednisone | 3件: D00238
D00238
,
D00473
,
D03033
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 85 85 |
1778 | Azatioprina | 1件: Azathioprine Azathioprine | 2件: D00238
D00238
,
D03033
| - | - | 3件: 13 13, 96, 97 |
1779 | AZATIOPRINA ASPEN - 50 COMPRESSE | 1件: Azathioprine Azathioprine | 2件: D00238
D00238
,
D03033
| - | - | 1件: 96 96 |
1780 | AZATIOPRINA HEX. 50CPR 50MG BL | 1件: Azathioprine Azathioprine | 2件: D00238
D00238
,
D03033
| - | - | 1件: 13 13 |
1781 | AZD0328 | - | - | - | - | 1件: 6 6 |
1782 | AZD0530 | - | - | - | - | 1件: 272 272 |
1783 | AZD0530 Difumarate | - | - | - | - | 1件: 272 272 |
1784 | AZD1236 | - | - | - | - | 1件: 299 299 |
1785 | AZD2014 | - | - | - | - | 1件: 34 34 |
1786 | AZD3241 | - | - | - | - | 2件: 6 6, 17 |
1787 | AZD3241 100mg | - | - | - | - | 1件: 17 17 |
1788 | AZD3241 300 mg BID | - | - | - | - | 1件: 6 6 |
1789 | AZD3241 300mg | - | - | - | - | 1件: 17 17 |
1790 | AZD3241 600 mg BID | - | - | - | - | 1件: 6 6 |
1791 | AZD3241 Alternative titration scheme with formulation 1 or 2 | - | - | - | - | 1件: 6 6 |
1792 | AZD3241 ER formulation 1 | - | - | - | - | 1件: 6 6 |
1793 | AZD3241 Extended release tablets 100 mg | 1件: Manganese citrate Manganese citrate | - | - | - | 1件: 6 6 |
1794 | AZD3241 Extended release tablets 25 mg | 1件: Manganese citrate Manganese citrate | - | - | - | 1件: 6 6 |
1795 | AZD4017 | - | - | - | - | 1件: 75 75 |
1796 | AZD4017 and prednisolone | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 75 75 |
1797 | AZD4831 | - | - | - | - | 1件: 86 86 |
1798 | AZD5055 | - | - | - | - | 1件: 85 85 |
1799 | AZD5634 | - | - | - | - | 1件: 299 299 |
1800 | AZD5634 for infusion | - | - | - | - | 1件: 299 299 |
1801 | AZD5634 for inhalation | - | - | - | - | 1件: 299 299 |
1802 | AZD5672 | - | - | - | - | 1件: 46 46 |
1803 | AZD6244 | - | - | - | - | 1件: 34 34 |
1804 | AZD7325 | - | - | - | - | 1件: 206 206 |
1805 | AZD7325 (High-Dose) | - | - | - | - | 1件: 206 206 |
1806 | AZD7325 (Low-Dose) | - | - | - | - | 1件: 206 206 |
1807 | AZD7986 | - | - | - | - | 2件: 44 44, 299 |
1808 | AZD9056 | - | - | - | - | 2件: 46 46, 96 |
1809 | AZD9056 hydrochloride | - | - | - | - | 1件: 46 46 |
1810 | AZD9567 | - | - | - | - | 1件: 46 46 |
1811 | AZD9567 10 mg | - | - | - | - | 1件: 46 46 |
1812 | AZD9567 125 mg | - | - | - | - | 1件: 46 46 |
1813 | AZD9567 155 mg | - | - | - | - | 1件: 46 46 |
1814 | AZD9567 20 mg | - | - | - | - | 1件: 46 46 |
1815 | AZD9567 40 mg | - | - | - | - | 1件: 46 46 |
1816 | AZD9567 80 mg | - | - | - | - | 1件: 46 46 |
1817 | AZD9567 Monohydrat | - | - | - | - | 1件: 46 46 |
1818 | AZD9567 monohydrate | - | - | - | - | 1件: 46 46 |
1819 | AZD9668 | - | - | - | - | 1件: 299 299 |
1820 | Azilect | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 4件: 2 2, 5, 6, 17 |
1821 | AZILECT 1 mg comprimidos | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
1822 | Azilect 1mg | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1823 | AZILECT® | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1824 | AZILECT® 1 mg Tabletten | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 2 2 |
1825 | Azithromycin | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 6件: 13 13, 84, 85, 96, 228, 299 |
1826 | Azithromycin (Zitromax°) | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 1件: 228 228 |
1827 | Azithromycin + Metronidazole | 2件: Azithromycin Azithromycin, Metronidazole | 6件: D00409
D00409
,
D02134
,
D05016
,
D05017
,
D06390
,
D07486
| - | - | 1件: 96 96 |
1828 | Azithromycin + N-acetylcystein + inhaled corticosteroid | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 1件: 228 228 |
1829 | Azithromycin 250 mg tablets | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 1件: 299 299 |
1830 | Azithromycin 250Mg Capsule | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 1件: 84 84 |
1831 | Azithromycin 500 mg film-coated tablet | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 1件: 299 299 |
1832 | AZITHROMYCIN DIHYDRATE | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 2件: 228 228, 299 |
1833 | Azithromycin monohydrate | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 1件: 84 84 |
1834 | AZITHROMYCINE | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 1件: 228 228 |
1835 | AZITHROMYCINE 250 mg | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 1件: 228 228 |
1836 | AZLI | - | - | - | - | 1件: 299 299 |
1837 | AZLI 75 mg three times a day (TID) | - | - | - | - | 1件: 299 299 |
1838 | AZLI 75 mg three times daily (TID) | - | - | - | - | 1件: 299 299 |
1839 | AZLI 75 mg two times a day (BID)/ three times a day (TID) | - | - | - | - | 1件: 299 299 |
1840 | AZLI 75 mg two times a day (BID)/three times a day (TID) | - | - | - | - | 1件: 299 299 |
1841 | AZM | - | - | - | - | 1件: 228 228 |
1842 | AZP-3601 | - | - | - | - | 1件: 235 235 |
1843 | AZP-531 | - | - | - | - | 1件: 193 193 |
1844 | AZP2006 oral solution | - | - | - | - | 1件: 5 5 |
1845 | AZT | - | - | - | - | 3件: 94 94, 265, 325 |
1846 | AZT/3TC | - | - | - | - | 1件: 265 265 |
1847 | Aztreonam | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 2件: 228 228, 299 |
1848 | Aztreonam for Inhalation (AI) | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 1件: 299 299 |
1849 | Aztreonam for Inhalation Solution | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 1件: 299 299 |
1850 | Aztreonam for Inhalation Solution (AZLI) | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 1件: 299 299 |
1851 | AZTREONAM LYSINE | 2件: Aztreonam Aztreonam, Lysine | 3件: D00240
D00240
,
D02304
,
D06558
| - | - | 1件: 299 299 |
1852 | Aztreonam Lysine for Inhalation | 2件: Aztreonam Aztreonam, Lysine | 3件: D00240
D00240
,
D02304
,
D06558
| - | - | 1件: 299 299 |
1853 | Aztreonam Lysine for Inhalation (AZLI) | 2件: Aztreonam Aztreonam, Lysine | 3件: D00240
D00240
,
D02304
,
D06558
| - | - | 1件: 228 228 |
1854 | Aztreonam solución para inhalación | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 1件: 299 299 |
1855 | Aztreonan lysine | 1件: Lysine Lysine | 1件: D02304
D02304
| - | - | 1件: 299 299 |
1856 | Aún no establecido | - | - | - | - | 1件: 53 53 |